Description,Guidance,3,4,5,6,7,8,Matched_Sentence,Remaining_Text
Quality Management System,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Quality Management System Fundamental Standard of
Practice (QMS FS)
The laboratory must have a Quality Management System
(QMS) that continuously assesses and improves the quality of
laboratory services and ensures compliance with regulatory
requirements. The laboratory director, and where appropriate,
the owner, must be involved in designing and implementing the
QMS.
The QMS must:
a) set quality goals, quality indicators, and performance
expectations and/or thresholds;
b) ensure quality goals are reviewed on a scheduled basis,
and performance expectations are met;
c) continuously monitor for deviations from quality goals or
performance expectations;
d) include scheduled system and process audits, at least
annually; and
e) have a system for correcting and documenting
problems uncovered by monitoring or audits.
Statutory authority: Article 5, Title 5 Public Health Law
Section 575(2) and (3)"
Quality Management System,,,,,,,,,
,Guidance,,,,,,,,Standard
,"The Quality Management System (QMS) must include
documents to describe personnel roles and responsibilities,
and the processes they must use to meet quality goals and
performance expectations.
The laboratory should document how QMS requirements for (a)
through (n) are met. Documentation may be in the form of a
quality manual, master index or cross reference system.
Examples of QMS documents include, but are not be limited to:
• standard operating procedures, policies, plans, etc.;
• maintenance procedures; and
• forms, instructions, and client information.
Please see additional information related to quality indicators
at: https://www.wadsworth.org/regulatory/clep/clinical-
labs/obtain-permit/on-site-survey.",,,,,,,,"Quality Management System Standard of Practice 1 (QMS
S1): Quality Goals and Performance Expectations
The laboratory’s Quality Management System (QMS) must
define quality goals and performance expectations that ensure
the quality and timeliness of laboratory services. The QMS
must meet New York State Clinical Laboratory Standards of
Practice and any other applicable requirements for all
laboratory processes.
The laboratory’s QMS must be documented and address the
following:
a) quality indicators (QI);
b) director responsibilities;
c) human resources;
d) facility design;
e) laboratory safety;
f) laboratory information systems (LIS);
g) resource management;
h) document control;
i) pre-analytic systems;
j) analytic systems;
k) post-analytic systems;
l) document and specimen retention;
m) proficiency testing; and
n) investigations and corrective actions."
Quality Management System,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Statutory authority: Article 5, Title 5 Public Health Law
Section 575(2) and (3),
Regulatory authority: 10 NYCRR subdivision 58-1.2(c) and
paragraph 19.3(c)(3)"
,"There must be a designated position for a quality systems
manager or quality assurance officer and a job description. The
designated individual must have the education, experience and
authority to discharge the responsibilities of the position and
must have access to personnel at all levels of the laboratory
organization as required. The designated individual is expected
to be a resource person to the Department when there is a
need for document review and compliance assessment. The
laboratory director may serve as the quality systems manager.
Persons who limit their scope of activity to oversight of quality
system activities do not require licensure by the New York
State Education Department.",,,,,,,,"Quality Management System Standard of Practice 2 (QMS
S2): Quality Systems Manager
The laboratory director must designate a quality systems
manager or quality assurance officer who has the experience
and authority to ensure communication, training, competency
assessment and ongoing compliance monitoring with all
requirements of the laboratory’s Quality Management System
(QMS).
Regulatory authority: 10 NYCRR subdivision 58-1.2(c)"
,"Additional examples of areas where QI are valuable in
assessing performance include acceptable specimen transport
and storage, acceptable performance by contract and
reference laboratories, verification of materials, quality control
records and review, temperature and humidity records and
comparability of test results.
a) Examples include specimens with missing information (e.g.,
time of collection when required) or incorrect labels, etc.",,,,,,,,"Quality Management System Standard of Practice 3 (QMS
S3): Quality Indicators
The laboratory must establish quality indicators (QI) that
assess the quality of laboratory services and identify processes
that do not meet Quality Management System (QMS)
requirements for quality goals and performance expectations.
The laboratory must establish QI for the following, at a
minimum:
a) monitoring specimen submissions, including compliance
with test request requirements and the laboratory’s
specimen submission instructions;"
Quality Management System,,,,,,,,,
,Guidance,,,,,,,,Standard
,"d) Examples include numbers of corrected test reports and
timeliness of client notification.
e) The laboratory must select a representative sampling of
STAT or urgent tests for turnaround time monitoring.",,,,,,,,"b) timeliness and completeness for personnel training and
competency;
c) performance on proficiency testing and alternative
assessments of test accuracy and reliability;
d) corrected test reports;
e) turnaround times for urgent or STAT tests;
f) complaint investigations; and
g) nonconformances.
Statutory authority: Article 5, Title 5 Public Health Law
Section 575(2) and (3)"
,"Examples of documentation may include: (1) continued
acceptable performance expectations (e.g., measured against
a threshold or benchmark); (2) areas in need of improvement;
and/or (3) non-conforming events as indicated when
performance expectations are not met.
Actions may include notifying clients or other appropriate
parties when requirements for the laboratory are not met (e.g.,
specimen collection instructions or test request requirements).",,,,,,,,"Quality Management System Standard of Practice 4 (QMS
S4): Quality Indicator Monitoring
The laboratory must have standard operating procedures
and/or policies describing the process for monitoring quality
indicators (QI).
For QI, the laboratory director is responsible for establishing:
a) the frequency for monitoring, which must be at least
annually;
b) how data will be collected, analyzed and documented;
c) acceptable performance and/or threshold(s) for each
indicator; and
d) actions to be taken for QI that do not meet defined
performance expectations and/or threshold(s), including
notifications to appropriate parties, if applicable."
Quality Management System,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Statutory authority: Article 5, Title 5 Public Health Law
Section 575(2) and (3)"
,"The laboratory must perform internal audits. Audits or “mock
inspections” that are performed to assess the laboratory’s
compliance with the requirements of regulatory or accreditation
programs may not be used as the only means to meet this
requirement.
Audits must be performed annually; however, these audits may
be performed for specific areas of the laboratory such that the
entire laboratory is audited over a two (2) year period.",,,,,,,,"Quality Management System Standard of Practice 5 (QMS
S5): System and Process Audits
The laboratory must perform internal audits designed to identify
systems and processes that do not meet quality goals and
performance expectations as defined by the laboratory’s
Quality Management System (QMS).
Standard operating procedures and/or policies must define the
audit processes, including, but not limited to:
a) audit methods;
b) audit frequency, which must be at least annually;
c) preventive and/or corrective action of problems and
nonconformances identified during the audit process;
and
d) designation of staff responsible for audits that, to the
extent possible, limit personnel from auditing their own
activities.
Regulatory authority: 10 NYCRR subdivision 58-1.2(c) and
paragraph 19.3(c)(3)"
Quality Management System,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Quality Management System Standard of Practice 6 (QMS
S6): Quality Management System Documentation
All Quality Management System (QMS) activities must be
documented, including:
a) quality indicator (QI) identification and monitoring; and
b) findings and the actions taken from all audits and
inspections.
Statutory authority: Article 5, Title 5 Public Health Law
Section 575(2) and (3)
Regulatory authority: 10 NYCRR subdivision 58-1.2(c) and
paragraph 19.3(c)(3)"
,"Director review of summarized QMS activities from delegated
individuals may be documented through signature and date, or
documented attendance at a meeting where the information is
discussed. Password protected electronic signatures are
acceptable to demonstrate required review.",,,,,,,,"Quality Management System Standard of Practice 7 (QMS
S7): Management Review
Laboratory management must review and document outcomes
of findings related to Quality Management System (QMS)
activities. The director must set a review schedule.
Documentation of laboratory director review must be at least
annual. Laboratory staff must be informed of management
review findings and the resulting decisions.
Areas of mandatory management review include:
a) quality indicators (QI);
b) internal system and process audits;
c) external inspection reports;
d) changes in workload or test menu;"
Quality Management System,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"e) proficiency testing (PT) and alternatives to PT to assess
test accuracy and reliability;
f) nonconformances, including QI that do not meet
laboratory performance expectations, and any resulting
actions; and
g) feedback or suggestions from any source, including
complaints.
Reports of management review must be retained according to
Document and Specimen Retention Standard of Practice 1 and
must be available to the Department upon request.
Regulatory authority: 10 NYCRR subdivision 58-1.2(c) and
paragraph 19.3(c)(3)"
Director Responsibilities,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Director Fundamental Standard of Practice (DR FS)
The laboratory director is responsible for all aspects of
laboratory services. The laboratory director may delegate, in
writing, responsibility for a category to an assistant director
holding a CQ in a relevant category; however, the laboratory
director retains ultimate responsibility.
Statutory authority: Article 5, Title 5 Public Health Law
Section 577
Guidance –
Information on responsibilities of directors of clinical
laboratories and blood banks is available at:
https://www.wadsworth.org/regulatory/clep/laws.
Regulatory information for Section 58-1.1, Permit, and
instruction on applying for a certificate of qualification are
available at: https://www.wadsworth.org/regulatory/clep."
,,,,,,,,,"Director Standard of Practice 1 (DR S1): Compliance with
Local, State and Federal Statutes and Regulations
The laboratory director and owner are jointly and separately
responsible for ensuring that the laboratory complies with all
applicable local, state and federal laws, regulations and
requirements.
Statutory authority: Article 5, Title 5 Public Health Law
Section 575(3)
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
Director Responsibilities,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Information on obtaining an HCS account is available at:
https://www.wadsworth.org/regulatory/clep/clinical-labs/obtain-
permit/health-commerce.
The HCS coordinator is responsible for requesting additional
HCS accounts and assigning personnel roles in the HCS
Communications Directory.",,,,,,,,"Director Standard of Practice 2 (DR S2): Health Commerce
System
The laboratory director must:
a) obtain and affiliate a Health Commerce System (HCS)
account as part of the requirements for a clinical
laboratory permit;
b) assign an HCS coordinator, either themselves or
another person;
c) have a standard operating procedure and/or polices for
the HCS, including a schedule for maintaining the
currency and accuracy of all HCS user accounts for
their facility; and
d) ensure that all personnel with HCS access agree to
comply with the terms of the HCS security and use
policies.
Statutory authority: Public Health Law Article 5, Title 5
Sections 575(1)"
,"Section 58-1.2 of 10 NYCRR describes full-time or regular part-
time hours required for laboratory directors at:
https://www.wadsworth.org/regulatory/clep/laws.",,,,,,,,"Director Standard of Practice 3 (DR S3): Director and
Assistant Director Involvement and Time Commitment
The laboratory director and assistant director(s) must:
a) spend time on-site in the laboratory to direct and
supervise personnel; and"
Director Responsibilities,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"b) be available in person, by telephone and/or through
electronic consultation to the laboratory’s personnel and
clients.
Regulatory authority: 10 NYCRR subdivision 58-1.2(a)"
,"Director responsibilities are available in Part 19 of 10 NYCRR,
available at: https://www.wadsworth.org/regulatory/clep/laws.
Director responsibilities related to testing must be delegated to
personnel that are an assistant director or individual that
qualifies as a supervisor.",,,,,,,,"Director Standard of Practice 4 (DR S4): Director
Responsibilities
The laboratory director and sole assistant director(s) must
ensure compliance with all New York State Clinical Laboratory
Standards of Practice. Responsibilities may be delegated in
writing by the director. The director remains responsible for all
delegated responsibilities and must provide evidence of
ongoing evaluation for those delegated duties.
The director is responsible for:
a) compliance, evaluation and monitoring of laboratory’s
Quality Management System (QMS) according to New
York State Clinical Laboratory Standards of Practice,
including but not limited to:
i. the appropriateness of laboratory services,
including test procedures that meet the needs of
the users of laboratory services;
ii. requirements for quality indicators (QI), quality
goals and performance expectations;
iii. scheduled review of audits, outcomes,
management reviews, and on-going monitors of
conformance; and
b) providing effective administrative direction, including
budget planning and controls, in conjunction with the"
Director Responsibilities,,,,,,,,,
,Guidance,,,,,,,,Standard
,"g) Ability to perform supervisory functions are determined by
compliance with requirements in Human Resources
Standard of Practice 4.",,,,,,,,"individual(s) responsible for the financial management
of the laboratory;
c) providing advice to clients regarding the significance of
laboratory findings and ensuring that test reports
include information required for interpretation;
d) monitoring all work performed in the laboratory to
ensure that analytically and clinically valid data are
generated;
e) selecting all reference laboratories;
f) ensuring that sufficient and qualified personnel are
employed including:
i. defining the qualifications and responsibilities of
all laboratory testing personnel and documenting
training and/or competency;
ii. where applicable, personnel are not engaged in
practices limited by license or beyond the scope
of licensure; and
g) ensuring that supervisors have sufficient time to perform
their supervisory functions even if they have
testing/bench responsibilities;
h) competency assessment of assistant directors and
direct-report personnel;
i) specifying in writing the technical and administrative
responsibilities and duties of all laboratory personnel
and comply with all Human Resource Standards of
Practice;"
Director Responsibilities,,,,,,,,,
,Guidance,,,,,,,,Standard
,"m) Approval of new and revised test procedures may not be
delegated by the laboratory director or sole assistant
director.",,,,,,,,"j) ensuring that all delegated duties are performed by staff
at defined intervals, and as needed;
k) promoting a safe laboratory environment to protect the
public and personnel, including, as required, limited or
restricted access;
l) providing continuing education to laboratory testing
personnel that is relevant to laboratory practices;
m) ensuring that current and approved test procedures are
available and accessible to all personnel;
n) effectively implementing a plan of correction to
deficiencies identified;
o) ensuring that the laboratory complies with all proficiency
testing requirements within the New York State Clinical
Laboratory Standards of Practice;
p) maintaining an effective working relationship with
applicable accrediting and regulatory agencies,
administrative officials, and the medical community; and
q) directors who also function as supervisors must also
meet the requirements under Human Resources
Standard of Practice 4.
Regulatory authority: 10 NYCRR section 58-1.2 and
subdivision 19.3(c)"
Director Responsibilities,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Off-site or electronic storage systems are acceptable, provided
the laboratory can produce duplicates within twenty-four (24)
hours of a request from the Department.",,,,,,,,"Director Standard of Practice 5 (DR S5): Document and
Records Accessibility
The laboratory director and owner are jointly and separately
responsible for ensuring that all standard operating procedures,
policies, manuals, plans, corrective actions, investigations and
any other associated documents are:
a) available for the recreation of the test process
for reported specimens;
b) available to the Department for review within
twenty-four (24) hours of the Department’s
request;
c) provided for the Department’s records when
requested; and
d) compliant with Document and Specimen
Retention Standards of Practice or according to
other applicable state and federal requirements,
whichever is longer.
Statutory authority: Article 5, Title 5 Public Health Law
Section 577
Regulatory authority: 10 NYCRR subdivisions 58-1.10(c)
and 58-1.11(c)"
Human Resources,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Testing personnel credentials, duties and responsibilities are
specified in 10 NYCRR Part 19 and in the following
subdivisions of 10 NYCRR Part 58: 58-1.2 Laboratory director,
58-1.3 Clinical laboratory supervision, 58-1.4 Qualifications of
laboratory supervisor, and 58-1.5 Duties and qualifications of
clinical laboratory technical personnel.
10 NYCRR Parts 19 and 58 are available at:
https://www.wadsworth.org/regulatory/clep.",,,,,,,,"Human Resources Fundamental Standard of Practice (HR
FS)
The laboratory must have effective leadership and personnel
with the education, training and experience necessary for the
delivery of laboratory services.
Statutory authority: Public Health Law Article 5, Title 5
Sections 575(2) and (3)"
,"Job descriptions should include, but are not limited to:
specimen collection personnel; testing personnel; supervisors;
laboratory managers; administrators; assistant director(s); and
laboratory director(s).",,,,,,,,"Human Resources Standard of Practice 1 (HR S1):
Organization Charts and Job Descriptions
Laboratory management must have an organizational chart(s)
and job descriptions for all personnel.
Job descriptions must be:
a) consistent with responsibilities and duties described in
the New York State Clinical Laboratory Standards of
Practice;
b) specified in writing for all positions and titles within the
laboratory, including positions/titles held by consultants;
and
c) describe qualifications.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(6) and
subdivision 58-1.2(d)"
Human Resources,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Duties and qualifications for laboratory supervisors and
cytology supervisors are described 10 NYCRR subpart 58-1,
available at www.wadsworth.org/regulatory/clep.
Requirements for licensure through the New York State
Education Department are available at: www.op.nysed.gov.
For out-of-state laboratories: diplomas, transcripts, curriculum
vitae, and/or work history; letters from former employers; or
other records should be maintained to establish that education
and experience requirements have been met. If the diploma
does not state the specific academic major, then transcripts are
required.
Individuals educated in a college or university outside the
United States should refer to the CLEP Program Guide for a
description of acceptable credentials and evaluation policies,
available at: https://www.wadsworth.org/regulatory/clep.",,,,,,,,"Human Resources Standard of Practice 2 (HR S2):
Personnel Records
The laboratory must document dates of employment for testing
personnel and verify the following:
a) relevant licensure when required by state law; and
b) educational and professional qualifications.
Personnel records must be retained according to Document
and Specimen Retention Standard of Practice 2.
Regulatory authority: 10 NYCRR subdivision 58-1.2(d)"
,"For emergency testing performed without a supervisor on-site,
the director should establish the maximum time period between
reporting of test results and the review.",,,,,,,,"Human Resources Standard of Practice 3 (HR S3):
Supervisor Staffing
The laboratory must have a supervisor or supervisor-qualified
individual, as delegated by the laboratory director in writing,
that is on the laboratory premises during all hours in which
tests are performed.
This requirement does not apply to testing for emergency
purposes, provided:
a) the person performing the test qualifies as a clinical
laboratory technologist;"
Human Resources,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"b) the director has defined requirements for supervisory
review of test results, including quality control;
c) the results are reviewed by the supervisor or director
during his or her next duty period; and
d) a record is maintained to reflect review by the
supervisor or director.
Regulatory authority: 10 NYCRR subdivision 58-1.3(d)"
,"Qualifications for laboratory supervisors and cytology
supervisors are described 10 NYCRR Part 58, available at:
https://www.wadsworth.org/regulatory/clep/laws.
For individuals not previously qualified under 10 NYCRR Part
58 to serve as a technologist or cytotechnologist, the
experience requirement must be met subsequent to obtaining a
license issued by the New York State Education Department.
Personnel assigned testing supervisory duties must meet the
education and experience requirements of a supervisor
regardless of the title (i.e., lead tech) the laboratory uses for the
position.",,,,,,,,"Human Resources Standard of Practice 4 (HR S4):
Supervisor Responsibilities
Laboratory supervisors must fulfill the requirements of this
Standard. Responsibilities may be delegated in writing to an
individual that qualifies as a laboratory supervisor but does not
hold the title of laboratory supervisor. Supervisors remain
responsible for all delegated activities and must provide
evidence of ongoing evaluation for those duties at regular
intervals, as defined by the laboratory director.
Laboratory supervisor responsibilities include:
a) supervising testing personnel;
b) monitoring and ensuring that acceptable performance
specifications are maintained, including:
i. review of quality control;
ii. scheduled instrument and equipment
maintenance;
iii. other quality assurance activities as assigned;
and"
Human Resources,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"c) ensuring test system performance:
i. by initiating preventive and/or remedial actions
when test procedures deviate from the
laboratory's established performance
specifications;
ii. in the event of nonconformances, ensuring that
test results are not reported until corrective
action has been taken and the test is performing
according to laboratory established performance
specifications; and
d) verifying that personnel are trained and deemed
proficient prior to performing testing on patient
specimens independently;
e) ensuring that staff have competency assessments as
needed; and
f) ensuring action is taken when personnel do not perform
as expected on competency assessments.
Regulatory authority: 10 NYCRR sections 58-1.3 and 58-1.4"
,,,,,,,,,"Human Resources Standard of Practice 5 (HR S5): Testing
Personnel Responsibilities
Testing personnel must fulfill the requirements of this Standard.
Testing personnel responsibilities include:
a) following the laboratory's pre-analytic and analytic
procedures and maintaining records of tests;"
Human Resources,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"b) maintaining records that demonstrate that proficiency
testing samples are tested in the same manner as
patient specimens;
c) adhering to the laboratory's quality assurance
procedures, including documenting all:
i. quality control activities;
ii. instrument and equipment verifications;
iii. maintenance and preventive maintenance; and
d) following the laboratory's policies and procedures
whenever test systems are not within the laboratory's
established performance specifications;
e) identifying and documenting problems that may
adversely affect test performance and notifying the
supervisor, assistant director(s) or director; and
f) documenting all corrective actions taken when test
systems deviate from the laboratory's established
performance specifications.
Regulatory authority: 10 NYCRR section 58-1.5"
,"See specialty standards for additional training requirements,
including blood and transfusion services.
Off -site testing training, for example by test system
manufacturers, super user, train the trainers, training at other
networks/affiliates/health care systems or through industry-
sponsored workshops can be used in addition to
documentation of on-site specific training. Following off-site",,,,,,,,"Human Resources Standard of Practice 6 (HR S6): Training
for Testing and Non-testing Personnel
Laboratory management must have standard operating
procedures for the training and documentation of training for all
testing and non-testing staff."
Human Resources,,,,,,,,,
,Guidance,,,,,,,,Standard
,"training, staff must still demonstrate testing capabilities (e.g.,
calibration, quality control and maintenance training and
demonstration of testing proficiency) at the site where testing is
performed through the documentation required to meet this
standard.",,,,,,,,"Personnel must be trained and deemed proficient in all tasks
for which they are responsible.
Training of testing personnel must be performed at the site
where they perform their job, and re-training must be performed
anytime that the test method or instrument changes.
Training must be documented for all personnel, including
healthcare providers performing testing at the point of care,
staff engaged in the performance of supportive tasks such as
data entry, accessioning and reporting, and supervisory and
management staff.
Training, and documentation of such, must include the
following:
a) date of training and date deemed proficient to perform
tasks;
b) objectives of training;
c) methods to be used in training;
d) materials to be used in the training;
e) data integrity; and
f) criteria to assess the effectiveness of training and
personnel proficiency prior to clearing them to perform
tasks independently.
Documentation of training must be retained according to
Document and Specimen Retention Standard of Practice 2.
Regulatory authority: 10 NYCRR subdivision 58-1.2(d)"
Human Resources,,,,,,,,,
,Guidance,,,,,,,,Standard
,"If a supervisor or director/assistant director also functions as
testing personnel, he or she must also be competency
assessed for those functions as required in Human Resources
Standard of Practice 8.
Testing personnel performing delegated supervisory functions
must also be competency assessed for those supervisory
functions.",,,,,,,,"Human Resources Standard of Practice 7 (HR S7):
Competency Assessment – Supervisory Personnel
Supervisors must be assessed in their responsibilities
according to Human Resources Standard of Practice 4 and
their competency documented.
Competency assessments must be performed annually for all
tasks for which the supervisor is responsible and include, as
applicable:
a) the date of the assessment;
b) compliance with policies and procedures;
c) communication, including bringing problems and non-
conformities to the attention of laboratory management;
d) leadership and problem-solving capabilities;
e) allocation of assets for effective daily laboratory
operations; and
f) personnel management.
Competency assessments must be performed by delegated
supervisor qualified staff or the director or assistant director(s).
For direct report supervisors and assistant directors, the
laboratory director must approve these competencies.
Documentation of competency must be retained according to
Document and Specimen Retention Standard of Practice 2.
Regulatory authority: 10 NYCRR subdivision 58-1.2(d)"
Human Resources,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Documentation of the personnel’s test performance on the
competency assessment must contain enough specific detail
so that the evaluation can be substantiated. When using
previously analyzed specimens or samples, such as quality
controls or previously reported proficiency testing samples,
documentation must include both the original testing and
competency assessment test results.
Competency assessment must be performed and documented
for all laboratory personnel, including healthcare providers
performing testing at the point of care.",,,,,,,,"Human Resources Standard of Practice 8 (HR S8):
Competency Assessment – Testing Personnel
Testing personnel must be assessed in their responsibilities
according to Human Resources Standard of Practice 5, and
their competency documented.
Competency assessments must be performed at least
semiannually during the first year the individual tests patient
specimens and annually thereafter. If there is a change to the
test method or instrument, that causes testing personnel to
alter their test process, competency must be reevaluated and
documented prior to reporting patient test results and include
use of the new test method or instrument. Competency
assessments of testing personnel must be performed at the site
where personnel perform their job.
Competency assessments must be performed for all tasks for
which the testing personnel are responsible and include, as
applicable:
a) the date of the assessment and the ability to recreate
the test process used for the competency;
b) assessment of test performance through testing
previously analyzed specimens, internal blind testing
samples or external proficiency testing samples;
c) direct observation of employee’s duties by supervisor
qualified staff for compliance with each test procedure
performed;
d) direct observation of compliance with safe practices
required to perform specimen testing;"
Human Resources,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"e) direct observation of compliance with procedures for
instrument maintenance and function checks and/or
preventive maintenance and proper documentation, as
applicable;
f) review of intermediate test results or worksheets, quality
control records and proficiency testing results;
g) recording and reporting of test results;
h) assessment of problem-solving skills; and
i) assessment of competency of any delegated
supervisory functions.
Competency assessments must be performed by delegated
supervisor qualified staff, the laboratory director or assistant
director(s). For direct report supervisors and assistant directors,
the laboratory director must approve these competencies.
Documentation of competency must be retained according to
Document and Specimen Retention Standard of Practice 2.
Regulatory authority: 10 NYCRR subdivision 58-1.2(d)"
,"Competency assessment is required for personnel under the
authority of the laboratory director, including contract
employees.
Competency assessment must be documented for all non-
testing individuals who perform support tasks that are not
related to testing, such as data entry, accessioning, and
phlebotomy.",,,,,,,,"Human Resources Standard of Practice 9 (HR S9):
Competency Assessment – Non-testing Personnel
Non-testing personnel must be competency assessed if they
perform pre-analytic or post-analytic laboratory practices.
Competency assessments must be performed annually for all
tasks for which non-testing individuals are responsible, and
include, as applicable:"
Human Resources,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"a) direct observation of safe practices required to perform
their duties;
b) periodic review of work product for compliance with
standard operating procedures and applicable workload
limits; and
c) assessment of problem-solving skills.
Documentation of competency must be retained according to
Document and Specimen Retention Standard of Practice 2.
Regulatory authority: 10 NYCRR subdivision 58-1.2(d)"
,"Acceptable forms of continuing education include professional
meetings or industry-sponsored training/workshops.
Continuing education hours for part time or per diem staff may
not be prorated.
Cytotechnologists must follow the continuing education
requirements of 10 NYCRR subdivision 58-1.12(c).",,,,,,,,"Human Resources Standard of Practice 10 (HR S10):
Continuing Education
Continuing education must be provided to testing personnel by
the laboratory director and owner, as applicable, and must be
appropriately documented. A minimum of twelve (12) hours of
continuing education must be performed by laboratory testing
personnel per calendar year.
Documentation of continuing education must be maintained in
accordance with Document and Specimen Retention Standard
of Practice 2.
Regulatory authority: 10 NYCRR subdivision 58-1.2(d)"
Facility Design,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Facility Design Fundamental Standard of Practice (FD FS)
The laboratory’s facility design must meet its own applicable
Quality Management System (QMS) specifications and comply
with the requirements of this part. The laboratory director and
owner are jointly and separately responsible for requirements in
the New York State Clinical Laboratory Standards of Practice
and any other applicable local, state and federal requirements.
Statutory authority: Article 5, Title 5 Public Health Law
Sections 575(2) and (3)"
,"Environmental conditions include, but are not limited to
biological sterility, dust, electromagnetic interference, radiation,
humidity, electrical supply, temperature, water quality, and
sound and vibration levels.
Appropriate water quality, as required for each instrument, kit, or
test process, must be used for all testing. Laboratories must
consider water quality parameters, including but not limited to:
pH, silicate content, particulate matter, and bacterial and
organic content where applicable. Laboratories purchasing
water that has already been certified are not expected to
evaluate these parameters unless required by the manufacturer
or by the laboratory in its procedure manual.
Temperatures may be monitored with a continuous recording
thermograph. Temperatures may also be maintained and
monitored internally by an instrument, when required for testing,
provided test results are either not generated or are flagged
when temperatures are out of the acceptable range.",,,,,,,,"Facility Design Standard of Practice 1 (FD S1): Design and
Environment
The laboratory design and environment must be suitable for the
tasks performed, including but not limited to, adequate:
a) equipment, instruments, reagents, kits, supplies, and
any other materials required to provide clinical testing
service;
b) space, such that the workload can be performed without
compromising the quality of work or safety of personnel;
c) furnishings and technology infrastructure, including
communication and data processing systems;
d) energy sources that mitigate fluctuations and
interruptions, including applicable backup power;
e) lighting, ventilation, water, waste and refuse disposal,
and environmental controls;"
Facility Design,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Environmentally controlled spaces may also be monitored
through an electronic monitoring system. This should include a
process to notify staff when temperatures are outside
acceptable ranges.",,,,,,,,"f) safeguards, including controlled access, to protect
people, specimens, laboratory resources, data, and
patient information;
g) precautions to protect the integrity of specimens,
equipment, instruments, reagents, materials, and
supplies; and
h) space and conditions to store all records and materials
for the length of time specified in the Document and
Specimen Retention Standards of Practice.
Regulatory authority: 10 NYCRR section 58-1.6"
,"Environmental conditions include, but are not limited to
biological sterility, dust, electromagnetic interference, radiation,
humidity, electrical supply, temperature, water quality, and
sound and vibration levels.
Appropriate water quality, as required for each instrument, kit, or
test process, must be used for all testing. Laboratories must
consider water quality parameters, including but not limited to:
pH, silicate content, particulate matter, and bacterial and
organic content where applicable. Laboratories purchasing
water that has already been certified are not expected to
evaluate these parameters unless required by the manufacturer
or by the laboratory in its procedure manual.
Temperatures may be monitored with a continuous recording
thermograph. Temperatures may also be maintained and
monitored internally by an instrument, when required for testing,
provided test results are either not generated or are flagged
when temperatures are out of the acceptable range.",,,,,,,,"Facility Design Standard of Practice 2 (FD S2): Cleanliness,
Monitoring and Controlling the Laboratory Environment
The laboratory must:
a) monitor, control, and record environmental conditions
that may influence the quality of test results;
b) ensure documents used to record environmental
conditions are consistent with manufacturer
requirements and/or laboratory standard operating
procedures, if applicable; and
c) ensure that the laboratory and work areas are clean and
well maintained.
Regulatory authority: 10 NYCRR section 58-1.6"
Facility Design,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Environmentally controlled spaces may also be monitored
through an electronic monitoring system. This should include a
process to notify staff when temperatures are outside
acceptable ranges.",,,,,,,,
,"Additional examples of where separation of laboratory activities
may be needed include, but are not limited to:
• where testing poses a biological, chemical or radiological
hazard;
• where the work may be affected or influenced by not being
separated (e.g., nucleic acid amplification); and
• where an environment conducive to uninterrupted
work/enhanced attention to detail is required (e.g.,
cytopathology screening).
NOTE: General contamination prevention protocols are
expected to be in place for all procedures. Specific
requirements, which involve dedicated equipment and/or areas,
are applicable to target amplification methods.
Closed system amplification test (CSAT) instruments should be
segregated from areas in which specimens are routinely
processed to avoid cross-contamination.
a) Separate rooms are recommended for pre-amplification and
post-amplification procedures. If performed in the same
room, dedicated areas should be defined for each phase of
the work, e.g., reagent preparation, specimen preparation,
amplification and detection. Plugged (aerosol barrier) tips or
positive displacement pipets are recommended for pre-
amplification procedures. Use of disposable, powder-free
gloves are recommended.",,,,,,,,"Facility Design Standard of Practice 3 (FD S3): Separation
of Incompatible Activities
The laboratory must use separate spaces for incompatible
testing activities and have processes to prevent contamination.
Laboratories conducting target amplification must have
procedures to prevent nucleic acid contamination that include:
a) unidirectional workflow from pre- to post-amplification, if
needed;
b) work area(s), personal protective equipment, and testing
materials dedicated to pre-amplification procedures;
c) work area(s), personal protective equipment, and testing
materials dedicated to post-amplification procedures;
and
d) processes to prevent exposing specimens and pre-
amplification samples to amplification products.
Regulatory authority: 10 NYCRR section 58-1.6"
Laboratory Safety,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Laboratory Safety Fundamental Standard of Practice (LS
FS)
The laboratory director and owner are jointly and separately
responsible for ensuring that the laboratory is designed and
operated in a safe manner to protect laboratory staff and the
general public according to the New York State Clinical
Laboratory Standards of Practice and applicable local, state
and federal requirements.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,,,,,,,,,"Laboratory Safety Standard of Practice 1 (LS S1): Safety
Policy and Procedure Approval
The laboratory director, or individual delegated in writing by the
director, must review and approve all new and revised safety
standard operating procedures and/or policies before
implementation.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,,,,,,,,,"Laboratory Safety Standard of Practice 2 (LS S2): Safety
Policy and Procedure Training
The laboratory must have records of initial and annual safety
training for all laboratory personnel in applicable safety
standard operating procedures and/or policies."
Laboratory Safety,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Records of training must be retained according to Document
and Specimen Retention Standard of Practice 2.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,,,,,,,,,"Laboratory Safety Standard of Practice 3 (LS S3):
Occupational Injuries
The laboratory must have standard operating procedures
and/or policies for documenting and reporting occupational
injuries or illnesses.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,,,,,,,,,"Laboratory Safety Standard of Practice 4 (LS S4):
Occupational Injury Evaluation
To avoid recurrence, the laboratory’s Quality Management
System (QMS) must require documented evaluation of
occupational injury, illness and/or exposure reports.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,"The OSHA website
(www.osha.gov/SLTC/bloodbornepathogens/index.html)
provides information regarding OSHA’s Bloodborne Pathogens
standard (Title 29 of the Code of Federal Regulations
1910.1030) and details what employers must do to protect
workers following occupational exposures to blood and other
potentially infectious materials that may contain HIV, HBV or
HCV.
Laboratories are encouraged to contact their local public health
laboratory following exposure to high-risk pathogens listed as",,,,,,,,"Laboratory Safety Standard of Practice 5 (LS S5):
Occupational Exposure Response Procedures
The laboratory must have standard operating procedures for
responding to potential exposures to biohazardous agents or
specimens.
Procedure(s) must include, but not be limited to:
a) the person to notify in the event of a potential exposure
and/or known exposure;"
Laboratory Safety,,,,,,,,,
,Guidance,,,,,,,,Standard
,"HHS Select Agents or Overlap Select Agents in the Federal
Select Agent Regulations (42 CFR Part 73 – Public Health) or
any other infectious agents that meet the definition of Risk
Group 3 or 4 as defined by the World Health Organization
(WHO).
Procedures should provide options for the employee to
confidentially consult their own physician or a physician
provided by the laboratory. For high-risk pathogens, the
laboratory should consider identifying in advance medical
experts for consultation.",,,,,,,,"b) requirements to cease work immediately in the
laboratory area/section where the incident occurred;
c) appropriate first aid measures following an exposure
incident;
d) provisions for confidential medical evaluation and
follow-up, including consideration of post-exposure
prophylaxis when medically indicated; and
e) criteria for reevaluation of the laboratory’s relevant
biohazard risk assessment under Laboratory Safety
Standard of Practice 7.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,"For additional information on developing a chemical hygiene
plan, see OSHA’s standard on Occupational Exposure to
Hazardous Chemicals in Laboratories (29 CFR 1910.1450) and
the National Research Council’s 2011 publication titled Prudent
Practices in the Laboratory – Handling and Management of
Chemical Hazards.
Chemical Hygiene Plan(s) may be implemented at an
institutional level by a Safety Office.",,,,,,,,"Laboratory Safety Standard of Practice 6 (LS S6): Chemical
Hygiene Plan
The laboratory must develop, where required, a Chemical
Hygiene Plan (CHP) that defines the safety policies and
procedures for all chemicals used in the laboratory according to
the Occupational Safety and Health Administration’s (OSHA)
Laboratory Standard.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,"This Standard is not restricted to bloodborne pathogens and
includes any potentially infectious specimen or sample (e.g.,
urine, stool, cultures, isolates, etc.).
Guidance for conducting biohazard risk assessments can be
found in the reference titled Biosafety in Microbiological and
Biomedical Laboratories (BMBL), available from the Centers for
Disease Control and Prevention (CDC).",,,,,,,,"Laboratory Safety Standard of Practice 7 (LS S7):
Biohazard Risk Assessment
The laboratory must conduct and document a biohazard risk
assessment for all sections and areas of the laboratory
processing biohazardous agents or specimens that must
include:"
Laboratory Safety,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"a) identification of biohazardous agents and specimen
types handled by the laboratory;
b) identification of exposure risks associated with
laboratory procedures, such as aerosol-generating
procedures (e.g., centrifuging, vortexing, etc.) and the
use of sharps;
c) determination of the appropriate biosafety level and any
additional or enhanced precautions needed as indicated
by the risk assessment for each section and areas of
the laboratory processing biohazardous agents or
specimens; and
d) documentation of review, initially, after revisions and
annually, by the director or director designee, as
delegated in writing by the director.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,"A written Exposure Control Plan (ECP) is required, where
applicable, under OSHA’s bloodborne pathogen standard
(29CFR 1910.1030). Exposure control plan(s) may be
implemented at an institutional level.
A written biosafety plan or standard operating procedures shall
be developed to describe control measures for other
biohazards and exposure risks not considered under the scope
of the OSHA bloodborne pathogen standard, as applicable.
For additional information on biosafety risk assessment and
mitigation, see the Centers for Disease Control and Prevention",,,,,,,,"Laboratory Safety Standard of Practice 8 (LS S8):
Biohazard Risk Management
The laboratory must have standard operating procedures
and/or policies for controlling biohazard risk for all areas with
affected test processes. The procedures must be consistent
with the biohazard risk assessment required under Laboratory
Safety Standard of Practice 7. These policies and procedures
must describe appropriate safe work practices, personal
protective equipment (PPE), and safety equipment necessary
to control exposure risks and to comply with local, state and
federal regulations on occupational exposure to biohazardous"
Laboratory Safety,,,,,,,,,
,Guidance,,,,,,,,Standard
,"document Biosafety in Microbiological and Biomedical
Laboratories (BMBL).",,,,,,,,"agents and specimens, and to the institution's Exposure
Control Plan (ECP) for bloodborne pathogens.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,"For additional information, see the OSHA Bloodborne
Pathogens (29 CFR 1910.1030) standard and the Centers for
Disease Control and Prevention document Biosafety in
Microbiological and Biomedical Laboratories (BMBL).
Biohazard warning signs and labels must be designed to meet
the requirements of the bloodborne pathogen standard where
applicable.",,,,,,,,"Laboratory Safety Standard of Practice 9 (LS S9):
Biohazard Warning Signs and Labels
Biohazard warning labels must be affixed to containers of
regulated waste, sharps disposal containers, refrigerators,
freezers and other containers used to store, transport or ship
biohazardous agents or specimens.
Biohazard warning signs must be posted at all laboratory work
areas used to store or handle biohazardous agents or
specimens.
Clerical or data entry stations not requiring the use of personal
protective equipment (PPE) may be designated as such within
posted laboratory work areas at the discretion of the laboratory
director. However, these designated areas must be clearly
described in plans or procedures and communicated to staff.
Additionally, written procedures must be in place to prevent
accidental cross-contamination of writing instruments, phones,
keyboards, etc. in these clerical/data entry areas.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,"PPE should be worn whenever there is a risk of contact with
biohazardous agents or specimens. The type of PPE that
should be utilized in a particular laboratory work area or for a
particular procedure should be determined as part of the
biohazard risk assessment required under Laboratory Safety
Standard of Practice 7.",,,,,,,,"Laboratory Safety Standard of Practice 10 (LS S10):
Personal Protective Equipment for Biohazards
The laboratory director and owner must:
a) provide appropriate personal protective equipment
(PPE), consistent with the laboratory’s biohazard risk
assessment according to Laboratory Safety Standard of"
Laboratory Safety,,,,,,,,,
,Guidance,,,,,,,,Standard
,"For additional information, see the OSHA Bloodborne
Pathogens (29 CFR 1910.1030) standard, Personal Protective
Equipment Standard (1910.132), and the Centers for Disease
Control and Prevention document Biosafety in Microbiological
and Biomedical Laboratories (BMBL).",,,,,,,,"Practice 7 and at no expense to the employee;
b) ensure that PPE is accessible at the worksite, properly
maintained and that potentially contaminated PPE is not
stored in clean areas;
c) provide cleaning, maintenance and/or disposal of PPE
at no cost to the employee;
d) ensure that PPE is removed before leaving for non-
laboratory areas (e.g., restrooms, cafeteria or
administrative offices); and
e) ensure that respirators are used and maintained in
accordance with all OSHA’s Respiratory Protection
standard (29 CFR 1910.134).
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,"Biological Safety Cabinet selection and installation should be
determined based on the laboratory’s biohazard risk
assessment required under Laboratory Safety Standard of
Practice 7.",,,,,,,,"Laboratory Safety Standard of Practice 11 (LS S11):
Biological Safety Cabinets
Laboratories utilizing a biological safety cabinet (BSC) must:
a) test and certify the BSC functions according to
manufacturer specifications:
i. at the time of installation within the laboratory;
ii. any time the BSC is moved;
iii. at least annually thereafter; and
b) have a standard operating procedure to verify and
document the BSC is functioning properly prior to each
day of use;
c) have a documented procedure for decontamination of"
Laboratory Safety,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"the BSC with an appropriate disinfectant:
i. before and after each use;
ii. immediately following contamination (e.g., spill or
splash of a biological material or hazardous
chemical); and
d) train and document the training of staff in the use of a
BSC, as applicable, as part of initial employee training
and annually thereafter.
Training records must be retained according to Document and
Specimen Retention Standard of Practice 2.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,"The sharps procedure may be included in the Exposure Control
Plan (ECP), as required by OSHA’s Blood Borne Pathogens
standard.
The laboratory should annually evaluate their use of safe
needle devices and adopt newer technologies, when
applicable, according to the Needlestick Safety and Prevention
Act.",,,,,,,,"Laboratory Safety Standard of Practice 12 (LS S12):
Sharps
The laboratory must have standard operating procedures
and/or policies for the safe handling of sharps. The procedure
or policy must include, but not be limited to:
a) the laboratory’s criteria for accepting or rejecting
specimens that include needles;
b) prohibiting recapping of needles or removing needles
from syringes or other devices, unless it can be
demonstrated that no alternative is feasible or that such
action is required by a specific procedure;
c) prohibiting disposable needles from being bent,
sheared, broken or otherwise manipulated by hand;
d) requirements that sharps are placed in a puncture-proof,
leak-proof container for disposal;"
Laboratory Safety,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"e) provisions for adopting improved engineering and work
practice controls that reduce the risk of sharps injuries
whenever practical; and
f) provisions to ensure that training is conducted and
documented on the use of sharps, as applicable, as part
of initial employee training and annually thereafter.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,"When using household bleach (5.25% sodium hypochlorite), it
is recommended that 1:10 dilutions be prepared daily.",,,,,,,,"Laboratory Safety Standard of Practice 13 (LS S13):
Decontamination Procedures
The laboratory must have standard operating procedures
and/or policies for the cleaning and/or decontamination of work
surfaces, instruments and/or equipment. The procedures must
include:
a) the frequency of cleaning and decontamination;
b) appropriate cleaning products and/or disinfectants; and
c) provisions for cleaning/decontamination and warning
labels, as needed, prior to servicing and/or shipping.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,,,,,,,,,"Laboratory Safety Standard of Practice 14 (LS S14): Food
Storage
Food and drink must be stored outside of laboratory work
areas. Areas where food and drink are stored must be
designated for this purpose.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
Laboratory Safety,,,,,,,,,
,Guidance,,,,,,,,Standard
,"a) The OSHA website
(www.osha.gov/SLTC/bloodbornepathogens/index.html)
provides information regarding OSHA’s Bloodborne
Pathogens standard (Title 29 of the Code of Federal
Regulations 1910.1030) and details what employers must
do to protect workers with occupational exposure to blood
and other potentially infectious materials that may contain
HIV, HBV or HCV.
a) For additional information on laboratory design for
biohazards, see the Centers for Disease Control and
Prevention document Biosafety in Microbiological and
Biomedical Laboratories (BMBL).
b) The laboratory should have proper ventilation systems to
rid the area of fumes created from hazardous material.
OSHA limits for any hazardous chemicals, such as
formaldehyde or xylene, should not be exceeded.
b) For additional information on laboratory design and
ventilation for working with hazardous chemicals, see the",,,,,,,,"Laboratory Safety Standard of Practice 15 (LS S15):
Laboratory Facilities – Biohazards and Chemical Hazards
Laboratory facilities must be appropriately designed for
biohazards and chemical hazards.
The laboratory design must include:
a) for biohazards, a design consistent with biosafety
level(s) assigned and documented in the biohazard risk
assessment under Laboratory Safety Standard of
Practice 7, including:
i. a sink for handwashing located in the laboratory
that may be manually, hands-free, or
automatically operated or other adequate hand
washing facilities;
ii. flooring and furniture that can be cleaned and
decontaminated;
iii. work surfaces that are impervious to liquids and
resistant to moderate heat and the chemicals
used for cleaning and decontamination; and
iv. emergency eyewash equipment that is readily
available and routinely tested in accordance with
institutional policies, where required.
b) for chemical hazards, a design and ventilation
necessary for minimizing the potential for employee
exposure to hazardous chemicals and as described in
the Chemical Hygiene Plan required under Laboratory
Safety Standard of Practice 6, including:"
Laboratory Safety,,,,,,,,,
,Guidance,,,,,,,,Standard
,"National Research Council’s 2011 publication titled Prudent
Practices in the Laboratory – Handling and Management of
Chemical Hazards.
For additional information on recommended testing and
maintenance of emergency eyewashes and safety showers,
see the American National Standards Institute’s (ANSI)
consensus standard Z358.1 – 2014 Emergency Eyewash and
Shower Equipment.",,,,,,,,"i. a sink for handwashing located in the laboratory
that may be manual, hands-free, or
automatically operated or other adequate hand
washing facilities;
ii. chemically resistant and impermeable flooring;
iii. work surfaces that are chemically resistant,
smooth, and can be cleaned;
iv. emergency eyewash equipment or shower, that
is properly functioning and routinely tested
according to institutional policies, within the work
area for immediate use when an employee could
be exposed to injurious corrosive chemicals; and
v. local exhaust ventilation devices (e.g., chemical
fume hoods) appropriate to the materials and
operations in the laboratory.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
,"The laboratory must review applicable Department of
Transportation (DOT), United States Postal Service (USPS),
and International Air Transport Association (IATA)
requirements, as well as requirements that may be in place by
a commercial transporter.
U.S. Federal regulations require training for the transport of
hazardous materials every three (3) years, regardless of the
mode of transportation. For transport of hazardous materials by
air, both domestic and international, aviation transport
associations and international regulations require training every
two (2) years.",,,,,,,,"Laboratory Safety Standard of Practice 16 (LS S16):
Packaging and Shipping Requirements
The laboratory director must have policies that ensure
compliance with all applicable local, state and federal laws,
regulations and requirements for the packaging and shipping of
hazardous chemicals and/or infectious substances.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(14)"
Laboratory Safety,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Laboratories located in New York State must comply with
statutory requirements for storage, treatment and disposal of
Regulated Medical Waste (RMW) as cited in 6 NYCRR
IV.B.360,365 (DEC) and 10 NYCRR II.I.70 (DOH).",,,,,,,,"Laboratory Safety Standard of Practice 17 (LS S17):
Regulated Medical Waste Management
The laboratory director and owner must ensure compliance
with all applicable local, state and federal laws, regulations and
requirements for the disposal of regulated medical waste.
All laboratories must develop, document and implement
standard operating procedures and/or policies specific to the
management of regulated medical waste (RMW) generated on-
site and/or treated at the facility.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(11)"
Laboratory Information Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Laboratory Information Systems,"Fundamental Standard of
Practice (LIS FS)
The laboratory must have a system that manages information
necessary to receive and track specimens, and report results.
The information must be accurate, complete, and readily
accessible. The system(s) may be manual, electronic, or a
combination. All information must be retained as described in
Document and Specimen Retention Standards of Practice.
Statutory authority: Article 5, Title 5 Public Health Law
Sections 575(2) and (3)"
,,,,,,,,Laboratory Information Systems,"Standard of Practice 1
(LIS S1): Information System Accuracy and Reliability
The laboratory must have adequate manual or electronic
systems in place to ensure test results and other patient-
specific data are accurately and reliably sent from the point of
data entry, whether interfaced or entered manually, to final
report destination, in a timely manner. Test results and other
applicable laboratory information system (LIS) information must
be archived and retained according to Document and
Specimen Retention Standard of Practice 4.
Regulatory authority: 10 NYCRR subdivision 58-1.2(c)"
Laboratory Information Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Explicit written policies that specify staff access, by job title, to
the laboratory computer systems must be described and
include how the access is obtained, maintained and
inactivated.
a) Examples of quality goals and performance expectations
for an LIS may include accurate recording and transmission
of data, protections against the loss of data and back-up
systems for data, protection of confidential information, and
timely reporting.",,,,,,,Laboratory Information Systems,"Standard of Practice 2
(LIS S2): Laboratory Information Systems Standard
Operating Procedure
The laboratory must have standard operating procedures for
laboratory information systems (LIS) that include:
a) quality goals and performance expectations for the LIS,
as described in the laboratory’s Quality Management
System (QMS);
b) protection of personally identifiable information and
protected health information;
c) facility design requirements for proper system function,
such as power protection;
d) approval of procedures and LIS changes, as delegated
in writing by the laboratory director;
e) authorization for staff access and protection from
unauthorized access;
f) initial validation of system components and as required
for changes;
g) documentation of verification;
h) requirements and documentation for maintenance;
i) mechanism to ensure that previous data is retrievable
when the LIS is upgraded or replaced;
j) requirements for tracking and audit trails; and
k) steps to be followed if the system is not functioning.
Regulatory authority: 10 NYCRR subdivision 58-1.2(c)"
Laboratory Information Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Laboratory Information Systems,"Standard of Practice 3
(LIS S3): Laboratory Information System Training
The laboratory must have standard operating procedures that
instruct staff on the use of laboratory information systems (LIS)
as it relates to laboratory services.
All appropriate staff must be trained on use of the LIS,
including necessary retraining as determined by the director,
after any LIS modification. Training documentation must be
retained according to Document and Specimen Retention
Standard of Practice 2.
Regulatory authority: 10 NYCRR subdivision 58-1.2(c)"
,"The laboratory must have ongoing mechanisms, such as
double-keying or supervisory review, to ensure the accuracy of
manual entries by testing and non-testing personnel into the
LIS. The laboratory director must define the periodicity of any
supervisory review. Data-entry personnel must be trained and
competency assessed as specified under the Human
Resources section of these standards.",,,,,,,Laboratory Information Systems,"Standard of Practice 4
(LIS S4): Transcription Accuracy
The laboratory must have a system to ensure that any
manually transcribed information, including test request
information and/or test results, or electronically interfaced
request information and/or results, are accurately transcribed.
Regulatory authority: 10 NYCRR subdivision 58-1.2(c)"
,"Algorithms capable of learning should be verified using
independent training and test data sets and should not be
altered other than through a formal change and verification
process.
Autoverification should include an acceptable range of
outcomes.",,,,,,,Laboratory Information Systems,"Standard of Practice 5
(LIS S5): Calculation and Algorithm Verification
Calculations, analyses and algorithms used for testing and
reporting, and any changes to them, must be verified before
initial use for specimen reporting, including:
a) calculations performed during the test process;
b) autoverification and/or autorelease;"
Laboratory Information Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"c) analysis of large and/or complex data sets (e.g., next
generation sequencing (NGS));
d) algorithms that incorporate results from multiple tests or
data types to determine a risk score or other
interpretation; and
e) algorithms capable of learning.
Regulatory authority: 10 NYCRR subdivision 58-1.2(c)"
,"Timely reporting should be appropriate to the clinical need of
the test results. Hospitals that offer emergency room or acute
care should have a manual system that can be in place within
minutes.
This standard applies to on-site and remote data storage.",,,,,,,Laboratory Information Systems,"Standard of Practice 6
(LIS S6): Systems Failure
The laboratory must have policies to ensure that:
a) electronic data are backed up at a frequency that
minimizes the risk of data loss;
b) systems are in place to ensure data integrity and timely
reporting of results if the laboratory information system
(LIS) is out of service; and
c) data are retrievable within twenty-four (24) hours.
Regulatory authority: 10 NYCRR subdivisions 58-1.2(c) and
58-1.11(c)"
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Resource Management,"Fundamental Standard of Practice
(RM FS)
The laboratory director and owner are jointly and separately
responsible for resource management. Specifications
established by the laboratory’s Quality Management System
(QMS) for resources and resource management must be met
and comply with the New York State Clinical Laboratory
Standards of Practice.
The laboratory must have facilities, materials, equipment and
instruments to provide appropriate services as required under
Facility Design Standard of Practice 1. The laboratory must
have a continuity of operations plan to describe laboratory
testing services or alternative arrangements during a disaster
or other emergency.
Statutory authority: Article 5, Title 5 Public Health Law
Sections 575(2) and (3)"
General Resource Management,,,,,,,,,
,"A plan for continuity of operations may address internal and
external events, such as electrical/heating/AC failures, fire,
natural disasters (e.g. ice storm, earthquake), and terrorist
events.",,,,,,,General Resource Management,"Standard of Practice 1
(GRM S1): Continuity of Operations Plan
The laboratory must have standard operating procedures
and/or policies to provide services in the event of a natural,
intentional, or unintentional event that impairs operations.
The standard operating procedures and/or policies must
include:"
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"a) contact numbers for key staff and their roles in an
emergency/unexpected event;
b) arrangements for communication with clients regarding
the status of laboratory services; and
c) pre-established arrangements for long-term storage of
specimens and/or use of reference and contract
laboratories to test critical specimens.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(2) and
subdivision 58-1.10(g)"
,"Testing supplies includes all materials and supplies used in the
test process (e.g., pipettes, gloves, etc.).",,,,,,,General Resource Management,"Standard of Practice 2
(GRM S2): Testing Supplies
The laboratory must have systems to ensure that supplies
required for generating test results are available.
Failure to have testing supplies available when needed must be
regarded as a nonconforming event according to Investigation
and Corrective Action Standard of Practice 3 and investigated
according to Investigation and Corrective Action Standard of
Practice 4.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"This standard applies to physical resources and assets
including biological safety cabinets (BSC), fume hoods, etc.",,,,,,,General Resource Management,"Standard of Practice 3
(GRM S3): Manufacturer Requirements
The laboratory must use all physical resources in the laboratory
according to manufacturer instructions and/or requirements.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Documentation must include the signature of the person
determining acceptability and date that acceptability was
determined.
Acceptability may be accomplished by examining quality
control samples and verifying that results are acceptable,
provided the quality control challenge is designed appropriately
to be sensitive to substandard equipment or supplies quality.",,,,,,,General Resource Management,"Standard of Practice 4
(GRM S4): Verification – General Requirement
The laboratory must verify and document the suitability of
consumable materials, including acceptance and rejection
criteria, that affect the quality and/or timeliness of test results.
The laboratory must:
a) document prior to use for patient testing, that all
consumable materials used in testing meet
manufacturer or laboratory specifications;
b) maintain documents that include manufacturer
instructions and communications related to material
quality (e.g., manufacturer or vendor recall); and
c) discontinue use of any material that fails to meet
specifications and document actions taken.
Performance verification requirements for equipment and
instruments are provided in Laboratory Equipment and
Instrument Standard of Practice 3. Verification of reagents and
media must comply with Reagents and Media Standard of
Practice 2.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)
and section 58-1.6"
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
,"The laboratory is responsible for ensuring that all requirements
for equipment and instruments, such as preventive
maintenance and calibration, are met. Examples include
borrowed, shared, rented or leased items or use of items used
in another part of the facility.",,,,,,,General Resource Management,"Standard of Practice 5
(GRM S5): Support Material Verification
Laboratories that use testing materials and/or equipment and
instruments outside of their control must ensure that initial and
ongoing verifications are performed.
Regulatory authority: 10 NYCRR section 58-1.6"
,"Performance verification requirements for equipment that can
be reverified (e.g., thermometers, pipettes, timers, hygrometer
etc.) are provided in Laboratory Equipment and Instrument
Standard of Practice 3.
For consumables provided without a manufacturer expiration
date, the laboratory director must determine the expiration date
with empirical data, when possible. Manufacturers may
recommend expiration dates that are adopted by the laboratory
following director approval.
Expired items may be used for training, research or student
use. These materials must be clearly labeled as for
“Educational use only” or similar wording and be stored
separately from materials used and verified for clinical testing.
For panel cells, follow manufacture instructions.",,,,,,,General Resource Management,"Standard of Practice 6
(GRM S6): Expired Supplies
The laboratory must:
a) not use expired materials for testing unless the
manufacturer has provided written authorization to do
so; and
b) not conduct its own validation studies to extend the
shelf life of purchased reagents or other materials that
have a manufacturer-stated expiration date.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,General Resource Management,"Standard of Practice 7
(GRM S7): Computer Systems Security
The laboratory must have systems and protocols to ensure the
integrity of computer systems from internal and external
threats.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Laboratory Equipment and Instrument,,,,,,,,,
,,,,,,,,Laboratory Equipment and Instrument,"Standard of
Practice 1 (LEI S1): Hardware and Software Settings
The laboratory must have policies to ensure that unintended
modifications are not made to laboratory equipment and/or
instruments, both hardware and software, that would invalidate
test results. After maintenance, the laboratory must ensure that
hardware and software settings are returned to testing
conditions.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Records related to testing equipment and instruments must be
made available to the Department upon request.",,,,,,,Laboratory Equipment and Instrument,"Standard of
Practice 2 (LEI S2): Instrument and Equipment Records
For equipment and instruments, laboratories must maintain
documentation of:
a) the serial number or unique identifier and, if applicable,
version number; and
b) date(s) of:"
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"i. initial calibration, certification and/or
performance verifications;
ii. placement into service; and
iii. required recertification or performance
verifications, as applicable.
The laboratory must have a system to trace reported results to
the instruments used to produce a specific test result.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"The laboratory may have the manufacturer perform function
checks and/or performance verifications.
The laboratory must establish and/or verify performance
specifications prior to use for reporting patient specimens and
ensure that performance specifications are maintained.
The laboratory may use manufacturer’s instructions, operator’s
manuals, or other recommendations or may establish more
rigorous criteria. For example, increased frequency of pipettor
performance verification may be necessary based on the
volumes of liquids being delivered, the frequency of use, and/or
the viscosity of the liquids being handled.
For a laboratory developed test (LDT), function check and
performance verification criteria and frequency may be
established according to Test Performance Specification
Standard of Practice 2.
For immunohematology, quarterly performance verification of
revolutions per minute (RPM) and timer checks of centrifuges is
required under Immunohematology Standard of Practice 6. For
additional requirements in the category of immunohematology,",,,,,,,Laboratory Equipment and Instrument,"Standard of
Practice 3 (LEI S3): Function Checks and Performance
Verification of Instruments, Equipment and Test Systems
The laboratory must have standard operating procedures
and/or policies to perform function checks and to verify
performance of equipment, instruments and/or test systems.
The laboratory must document or retain electronic records of
function checks and performance verification results.
Function checks and performance verifications must:
a) meet manufacturer and laboratory established
performance specifications; and
b) be performed:
i. prior to specimen testing and at least annually;
ii. following service, repairs and/or updates; and
iii. at a frequency defined by the manufacturer
instructions; or
iv. in the absence of manufacturer instructions, at a"
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
,"please see section 10 NYCRR 58-2 at:
https://www.wadsworth.org/regulatory/clep/laws.",,,,,,,,"frequency established by the laboratory to
provide accurate and reliable test results.
Regulatory authority: 10 NYCRR section 58-1.6"
,,,,,,,,Laboratory Equipment and Instrument,"Standard of
Practice 4 (LEI S4): Performance Verification After
Relocation
After moving equipment and/or instruments that are not
intended to be portable, the laboratory must document
acceptable performance verification, function checks and/or
analysis of quality control materials prior to specimen testing.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"The standard operating procedures and/or policies may refer to
the use of up-to-date relevant manufacturer provided manuals
and directions for instructions on the maintenance and use of
equipment/instruments.",,,,,,,Laboratory Equipment and Instrument,"Standard of
Practice 5 (LEI S5): Instruction for Maintenance and
Preventive Maintenance
The laboratory must have standard operating procedures
and/or policies for the maintenance and preventive
maintenance of equipment and instruments that are readily
available to laboratory staff.
Regulatory authority: 10 NYCRR section 58-1.6"
,"Records must include copies of reports/certificates of all
calibrations and/or verifications including dates, times, and
results, adjustments, the acceptance criteria, and due date of
the next calibration and/or verification.",,,,,,,Laboratory Equipment and Instrument,"Standard of
Practice 6 (LEI S6): Maintenance and Preventive
Maintenance Records
The laboratory must perform and document maintenance for all
equipment and instruments used for specimen testing and
reporting."
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Documentation must include:
a) all scheduled maintenance and preventive maintenance
records;
b) instances and outcomes of damage, malfunctions,
modifications and/or repairs; and
c) dates of maintenance.
Regulatory authority: 10 NYCRR section 58-1.6"
,,,,,,,,Laboratory Equipment and Instrument,"Standard of
Practice 7 (LEI S7): Managing Defective Equipment and
Instruments
For defective equipment and/or instruments, the laboratory
must:
a) clearly label the equipment or instrument as being out of
service;
b) document and investigate the nonconformance
according to Investigation and Corrective Action
Standards of Practice 3 and 4;
c) examine and document the effect on specimen test
results; and
d) ensure that repaired or serviced equipment and
instruments meet manufacturer or laboratory defined
performance specifications through calibration,
performance verification and/or function checks, as
applicable, before being used for reporting test results.
Regulatory authority: 10 NYCRR section 58-1.6"
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
,"If the CO incubators have an automatic CO readout, the CO
2 2 2
level does not need to be tested daily with an electronic CO
2
analyzer.",,,,,,,Laboratory Equipment and Instrument,"Standard of
Practice 8 (LEI S8): Carbon Dioxide Incubators
The laboratory must measure and document carbon dioxide
(CO2) in CO2 incubators to be within a range that is
appropriate for the testing performed.
For incubators without a measurement system:
• measure levels daily using an outside CO
2
measurement device (e.g., electronic CO analyzer); or
2
For incubators with a measurement system:
• validate CO levels monthly using a separate
2
measurement device.
Regulatory authority: 10 NYCRR section 58-1.6"
,"b) Verification should include monitoring of temperature
ramping rates where applicable. Verification may be
performed indirectly by following manufacturer instructions
or rotating a low positive control across every well, over
time, or an electronic check for temperature homogeneity.",,,,,,,Laboratory Equipment and Instrument,"Standard of
Practice 9 (LEI S9): Thermal Cyclers and Polymerase Chain
Reaction
For procedures using a thermal cycler, the laboratory must:
a) operate the thermal cycler per the test kit
manufacturer’s instructions; and
b) verify the uniformity of temperature across all sample
chambers at inception, annually, and after servicing.
Regulatory authority: 10 NYCRR section 58-1.6"
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
Reagents and Media,,,,,,,,,
,"Reagent and media documentation must be made available to
the Department upon request. Inventory control should ensure
that the laboratory has sufficient reagents to verify new lots and
shipments.",,,,,,,,"Reagent and Media Standard of Practice 1 (RGM S1):
Reagent and Media Records
The laboratory must have an inventory control system for
reagents and media that documents, at a minimum, the:
a) lot number;
b) date of receipt in the laboratory;
c) date of acceptable performance verification(s);
d) date(s):
i. for reagents, when they are placed into service;
or
ii. for media, a mechanism that can identify
specimens affected should the media be
contaminated; and
e) expiration date.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"The laboratory must establish and/or verify performance
specifications prior to use for reporting patient specimens and
ensure that performance specifications are maintained.
Verification may be accomplished by examining quality control
samples and verifying that results are acceptable, provided the
quality control challenge is designed appropriately to be
sensitive to substandard equipment or supplies quality.",,,,,,,Reagents,"and Media Standard of Practice 2 (RGM S2):
Verification of Reagents and Media – Control Procedures
The laboratory must follow the manufacturer instructions for
using reagents, media and supplies.
In addition, unless more stringent requirements are specified
elsewhere in the New York State Clinical Laboratory Standard
of Practice, the laboratory must:"
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Antibody identification cell panels must be used according to
manufacturer instruction.",,,,,,,,"a) check each batch (prepared in-house), lot number
(commercially prepared) and shipment of reagents,
disks, stains, antisera, and identification systems
(systems using two (2) or more substrates or two (2) or
more reagents, or a combination) when prepared or
opened for positive and negative reactivity, as well as
graded reactivity, if applicable;
b) each day of use, test staining materials for intended
reactivity to ensure predictable staining characteristics.
Control materials for both positive and negative
reactivity must be included, as appropriate;
c) check fluorescent and immunohistochemical stains for
positive and negative reactivity each time of use;
d) before, or concurrent with the initial use:
i. check each batch of media for sterility if sterility is
required for testing;
ii. check each batch of media for its ability to support
growth and, as appropriate, select or inhibit
specific organisms or produce a biochemical
response; and
iii. document the physical characteristics of the media
when compromised and report any deterioration in
the media to the manufacturer.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Reagents,"and Media Standard of Practice 3 (RGM S3):
Labeling
The laboratory must label all reagents and media, as
applicable, with the:
a) identity;
b) titer, strength or concentration;
c) storage conditions;
d) in-house preparation date or date opened;
e) identity of the person who prepared or opened the
material;
f) expiration date and expiration after opening, if pertinent
to the performance of the reagent; and
g) any additional relevant information.
If a container cannot be directly labeled due limitations of the
container (e.g., for tubed or plated in-house prepared
microbiological media), the required information may be
recorded in a manual or electronic tracking system, provided
that each container is traceable to an individual entry in the
tracking system.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,,,,,,,,Reagents,"and Media Standard of Practice 4 (RGM S4): Kit
Components
The laboratory must not interchange components of reagent
kits of different lot numbers unless:
a) specified by the manufacturer; or"
Resource Management,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"b) established and documented by the laboratory to meet
test performance specifications according to Test
Performance Specification Standard of Practice 2.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"For temperature sensitive reagents and media, the laboratory
must follow manufacturer instructions for freeze-thaw cycles or
establish its own criteria. Freeze-thaw cycles must be
documented where applicable.",,,,,,,Reagents,"and Media Standard of Practice 5 (RGM S5):
Reagent and Media Storage
For labile reagents and media that are required for testing and
that do not have manufacturer storage instructions, the
laboratory must establish and document storage conditions that
lead to acceptable test performance.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Document Control,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Document Control,"Fundamental Standard of Practice (DC
FS)
All standard operating procedures, policies, instructions,
programs, plans and manuals, and any other documents as
indicated in any part of the New York State Clinical Laboratory
Standards of Practice, must be maintained by the laboratory
under conditions of document control.
Statutory authority: Article 5, Title 5 Public Health Law
Sections 575(2) and (3)"
,"Electronic procedures must be accessible to all relevant staff at
all times. Backup systems are required to ensure accessibility if
electronic procedures are not available.",,,,,,,Document Control,"Standard of Practice 1 (DC S1):
Availability
All standard operating procedures, policies, instructions,
programs, plans and manuals, and any other documents as
indicated in any part of the New York State Clinical Laboratory
Standards of Practice must be:
a) under document control;
b) in a standardized format with a system of numbering
and/or titling of each procedure;
c) current and accurate; and
d) available and accessible at all times in applicable work
area(s).
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Document Control,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Document Control,"Standard of Practice 2 (DC S2):
Compliance
Laboratory staff must follow all standard operating procedures
and other laboratory documents that are under document
control. The laboratory must have systems established to:
a) notify relevant staff of revisions; and
b) provide and document training for staff on procedures
and other applicable documents.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"All Document Control Standards of Practice apply to
manufacturer instructions, operator manuals, package inserts,
and/or or textbooks, etc., used in total or in part of the Test
Procedure, including director approval.",,,,,,,Document Control,"Standard of Practice 3 (DC S3):
Manufacturer Instruction Manuals
Current manufacturer’s instructions, operator manuals,
package inserts, or textbooks may be used in total or in part to
meet Test Procedure Content Standards of Practice 1 and 2 or
other document content requirements, provided that all relevant
content requirements in any part of the New York State Clinical
Laboratory Standards of Practice are fulfilled.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Procedure excerpts may also be referred to as job aides,
training notes, and/or procedural subsections.",,,,,,,Document Control,"Standard of Practice 4 (DC S4):
Procedure Excerpts
In addition to complete standard operating procedures,
policies, instructions, programs, plans and/or manuals,
excerpts that summarize key information may be used by
laboratory staff, provided:"
Document Control,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"a) the director, assistant director(s) or supervisor qualified
staff reviews the excerpts at least every two (2) years
and this review is documented; and
b) the content provided by the excerpt does not contradict
the corresponding document.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Non-testing documents may include safety policies and
procedures, computer system specifications and/or
maintenance instructions.
This standard is applicable to laboratory developed tests
(LDTs), as well as manufacturer instruction manuals adopted in
lieu of laboratory-specific test procedures, standard operating
procedures and/or excerpts.
In the case of a change in the laboratory director or sole
assistant director, all test procedures should be reviewed and
signed by the new director and/or sole assistant director as
soon as possible. If not done immediately, the laboratory
should have a plan for having the review completed and
documented within an appropriate timeframe, not to exceed six
(6) months.
Electronic signature, or an alternative system, may be
substituted for hard copy, as long as it is a password protected
signature.
Blood banks are required to follow the requirements in 10
NYCRR section 58-2.8 for annual review by the director or
authorized supervisor.",,,,,,,Document Control,"Standard of Practice 5 (DC S5): Director
Approval
The director or sole assistant director designated for a category
must sign and date each new or revised test procedure before
it is used for reporting patient test results. Approval of new and
revised test procedures, as indicated by signature and date,
may not be delegated by the director or sole assistant director.
Test procedure review, at a minimum every two (2) years, is
required by the director. This duty may be delegated in writing
to an assistant director holding an appropriate certificate of
qualification or an individual qualified as a laboratory
supervisor.
For controlled documents not related to testing, an individual
may be delegated by the laboratory director, as specified in
writing, to approve, sign and review documents as indicated in
the New York State Clinical Laboratory Standards of Practice.
Regulatory authority: 10 NYCRR subdivisions 58-1.2(c) and
58-1.10(g)"
Document Control,,,,,,,,,
,Guidance,,,,,,,,Standard
,"This activity is a critical element of document control whereby
test reports can be readily associated with test procedures in
place at the time a specific specimen was analyzed.",,,,,,,Document Control,"Standard of Practice 6 (DC S6):
Controlled Document Archival
The laboratory must have a system to:
a) maintain and archive a copy of each revised document
under document control, with the dates of use and
discontinuation; and
b) retain these records, if required, according to Document
and Specimen Retention Standards of Practice.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Pre-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Pre-Analytic Systems,"Fundamental Standard of Practice
(PRS FS)
The laboratory is responsible for establishing and maintaining
the:
a) integrity of specimen identification;
b) stability of specimens; and
c) completeness and accuracy of information essential to
the interpretation and reporting of test results.
Statutory authority: Article 5, Title 5 Public Health Law
Sections 575(2) and (3)"
Test Request,,,,,,,,,
,"This Standard does not prohibit the acceptance of specimens
for teaching or research purposes and does not apply to other
entities specifically exempted under Article 5, Title 5 of the
Public Health Law.",,,,,,,Test Request,"Standard of Practice 1 (TR S1): Specimen
Testing
All specimens must be received with a test request form or
electronic equivalent from persons authorized by law to order
testing. Only a New York State permitted clinical laboratory can
accept specimens for testing.
Regulatory authority: 10 NYCRR subdivisions 58-1.7(a) and
(b)"
Pre-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Test Request,"Standard of Practice 2 (TR S2): Verbal Test
Request
Following a verbal test request, persons authorized by law
must submit a written or electronic request within forty-eight
(48) hours. The laboratory must document efforts to obtain the
test request.
Regulatory authority: 10 NYCRR paragraph 58-1.7(b)(1)"
,,,,,,,,Test Request,"Standard of Practice 3 (TR S3): Test Request
Form
The test request form, or an electronic equivalent, must have
space for the following information, including but not limited to:
a) patient’s name or unique identifier;
b) gender and age or date of birth of the patient;
c) ordering and report release information, including:
i. name or unique identifier of the physician or
authorized ordering source; or
ii. if appropriate, the individual responsible for
using the test results; or
iii. the name and address of the laboratory
submitting the specimen for testing; and
iv. as applicable, a contact person to enable the
reporting of imminently life-threatening results or
panic or alert values; and
d) type of primary specimen and the anatomic site of
origin, where appropriate;"
Pre-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"e) test(s) requested;
f) date and, when required, time of primary specimen
collection;
g) date and time of receipt of specimens by the laboratory;
h) for Pap smears, the patient's date of onset of last
menstrual period, age, previous abnormal cytology, and
previous significant history; and
i) any additional information relevant and necessary for a
specific test to ensure accurate and timely testing and
reporting of results, including interpretation, if
applicable.
A patient’s chart or medical record may be used as the test
request or authorization, provided it includes all the information
indicated above and is available for review by the Department.
Test request records must be maintained in accordance with
Document and Specimen Retention Standard of Practice 7.
Regulatory authority: 10 NYCRR section 58-1.10"
,,,,,,,,Test Request,"Standard of Practice 4 (TR S4): Urgent Test
Request
The laboratory must have standard operating procedures
and/or policies for the receipt, labeling, processing, and
reporting of specimens that are marked as urgent or STAT.
The procedure must include instructions for reporting critical
and alert values.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Pre-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
Specimen Processing,,,,,,,,,
,"For blood bank specimen requirements see 10 NYCRR section
58-2.",,,,,,,Specimen Processing,"Standard of Practice 1 (SP S1):
Specimen Submission Instructions
The laboratory must have current and accurate instructions for
specimen identification, collection, handling and transportation
for all tests offered by the laboratory. The laboratory must
make the instructions available to those responsible for test
ordering, and specimen collection and handling.
The specimen submission instructions must include, if
applicable to the test(s) offered:
a) copies of or references to:
i. lists of available laboratory tests offered;
ii. consent forms;
iii. information and instructions provided to patients
for preparations before specimen collection;
iv. information for users of laboratory services that
includes the test method, testing algorithms and
medical indications for the selection of available
tests; and
b) requirements for:
i. identification and preparation of the patient for
specimen collection (e.g., instructions to
caregivers and phlebotomists);
ii. primary specimen collection with descriptions of
the specimen containers, order in which blood
specimens are to be drawn, any necessary"
Pre-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"additives, and storage; and
c) instructions for:
i. completion of test request form or electronic
request;
ii. the type and amount of specimen to be
collected;
iii. special timing of collection;
iv. any special handling needs between time of
collection and time received by the laboratory
(e.g., transport requirements, refrigeration,
warming, immediate delivery, etc.);
v. labeling of primary specimens with at least two
unique identifiers, and where appropriate,
specimen source;
vi. requirements for clinical information (e.g., history
of administration of drugs, gestational age, etc.);
vii. the positive identification of the patient by the
specimen collector;
viii. specimen processing at the collection site (e.g.,
centrifugation, serum separation, aliquoting,
freezing, etc.);
ix. recording the identity of the person collecting the
primary specimen;
x. safe disposal of materials used in collection; and
xi. chain of custody requirements including
guidelines for the packaging of specimens in a"
Pre-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"tamper-evident manner.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Examples of actions to be taken by the laboratory may include
notification to submitters detailing problems observed,
clarification of submission instructions, and/or training for
submitters.",,,,,,,Specimen Processing,"Standard of Practice 2 (SP S2):
Monitoring Specimen Submissions
The laboratory director, or individual that is delegated in writing
by the director, must monitor, document and take appropriate
action when specimens received do not comply with the
laboratory’s specimen submission instructions.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Interpretative statements made on reports that recommend
therapeutic intervention or provide a clinical characterization of
the patient must be supported by the intended use as indicated
in the package insert (for FDA cleared methods) or must be
supported by validation studies and receive approval for a
laboratory developed test (LDT) from the Department (see Test
Performance Specifications Standard of Practice 2).
Information on Departmental approval of a laboratory
developed test (LDT) is available at:
https://www.wadsworth.org/regulatory/clep/clinical-labs/obtain-
permit/test-approval.
Literature references alone are not sufficient to document
clinical validity. Laboratories that use FDA-cleared kits and
reagents and report interpretative statements that are not
supported by the intended use of the assay will be considered
to have modified the assay and will be required to submit
validation data that supports the interpretation.",,,,,,,Specimen Processing,"Standard of Practice 3 (SP S3):
Client Requests for Test Information
The laboratory must make available to clients a list of test
methods used by the laboratory and, as applicable, the
performance specifications of these methods. In addition,
information that may affect the interpretation of test results, for
example test interferences, must be provided upon request.
The laboratory must update this information with any changes
that affect test results or their interpretation.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(1) and
subdivision 58-1.10(g)"
Pre-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,"The laboratory may elect to analyze irreplaceable or critical
specimens.
If information is missing for irreplaceable or critical specimens,
the laboratory may choose to hold results until the requesting
physician, or person responsible for specimen collection,
provides the proper information. For corrections, the submitter
must attest to the accuracy of the changes, and documentation
of the change must be recorded by the laboratory.
Documentation of the change must be traceable to the
specimen.
If compromised specimens are tested, the final report must
indicate the nature of the problem and, if applicable, that
caution is required when interpreting the result, according to
Reporting Standard of Practice 2.",,,,,,,Specimen Processing,"Standard of Practice 4 (SP S4):
Acceptance and Rejection Procedure
The laboratory must have a standard operating procedure for
the acceptance and rejection of specimens. The laboratory
must document the reason(s) for rejecting a specimen and
notify the specimen submitter.
The procedure must describe criteria for rejecting specimens,
including:
a) evidence that the specimen is unsatisfactory for testing
or that it is inappropriate for the test requested;
b) evidence of improper collection, labeling, preservation,
handling or other conditions that make the specimen
unsatisfactory or unreliable for testing;
c) rejection of a specimen if the time between collection
and receipt in the laboratory has exceeded
requirements; and
d) the date and, when required, the time of collection is not
recorded on the test request.
Regulatory authority: 10 NYCRR subdivision 58-1.10(e)"
,,,,,,,,Specimen Processing,"Standard of Practice 5 (SP S5):
Accession Procedure and Documentation
The laboratory must have a standard operating procedure to
receive and document all specimens in an accession book,
worksheet, electronic or other comparable system."
Pre-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Documentation must include:
a) the unique accession number or other unique identifier
for the specimen;
b) the name or other identifier for the patient;
c) the date and time the specimen was received in the
laboratory;
d) the test(s) requested;
e) written or electronic documentation of verbal test
requests and communication with the authorized
ordering source to obtain a written test request;
f) in the event a specimen is forwarded to a reference
laboratory for testing:
i. the name of the laboratory;
ii. the date the specimen was sent to a reference
laboratory for testing;
iii. the date the specimen result(s) were reported;
and
g) a brief description of the condition in which
unsatisfactory specimens were received (e.g., broken,
leaked, hemolyzed, turbid, etc.).
Regulatory authority: 10 NYCRR paragraph 58-1.11(b)(1)"
Pre-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Specimen Processing,"Standard of Practice 6 (SP S6):
Specimen Transport
The laboratory must monitor that specimens have been
transported to the laboratory:
a) within the time frame required to achieve reliable test
result;
b) within a temperature range specified in the specimen
submission instructions and, where applicable,
appropriate preservatives or protections (e.g., protected
from light); and
c) in a manner that ensures safety and complies with all
local, state and federal transport requirements.
Regulatory authority: 10 NYCRR subdivision 58-1.10(d)"
,,,,,,,,Specimen Processing,"Standard of Practice 7 (SP S7):
Portion or Aliquot Identification and Integrity
Specimen portions or aliquots must be traceable to the original
specimen. Standard operating procedures for the preparation
and handling of specimen portions or aliquots must describe
measures to prevent the cross-contamination of primary and
specimen portions as required under Test Procedure Content
Standard of Practice 1.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Pre-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Specimen Processing,"Standard of Practice 8 (SP S8):
Specimen Storage
Specimens must be stored at conditions that ensure stability.
Appropriate conditions must be maintained, even during
temporary storage, and allow for additional testing.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)
and paragraph 58-1.11(d)(1)"
Reference and Contract Laboratories,,,,,,,,,
,,,,,,,,,"Reference and Contract Laboratory Standard of Practice 1
(RCL S1): Reference Laboratory Selection and Use
The laboratory must have a standard operating procedure for
selecting and using reference and/or contract laboratories,
including any secondary reference laboratories used by a
primary reference laboratory.
It is the responsibility of the director and owner to select and
use only reference and/or contract laboratories that:
a) hold valid New York State permit(s) in the category of
testing and any required test approvals;
b) use appropriate methods for the requested testing; and
c) have the capacity and resources to meet clinical and/or
contractual requirements.
Regulatory authority: 10 NYCRR subdivisions 58-1.1(b)
and 58-1.10(g)"
Pre-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Documentation that the reference or contract laboratory is
permitted should be included with the list.",,,,,,,,"Reference and Contract Laboratory Standard of Practice 2
(RCL S2): Registry of Reference and Contract Laboratories
The laboratory must maintain a list of all:
a) reference and/or contracted laboratories that it uses;
and
b) specimens that have been sent to another laboratory.
The name and address of the laboratory responsible for the
testing and result must be provided to users of laboratory
services.
Regulatory authority: 10 NYCRR subparagraph 58-
1.11(b)(1)(vi)"
,"Action taken by the director for a reference and/or contract
laboratory that does not perform acceptably includes written
notification of problems encountered or cancelation of the
contract.",,,,,,,,"Reference and Contract Laboratory Standard of Practice 3
(RCL S3): Performance Assessment of Reference and
Contract Laboratories
Laboratories must have a standard operating procedure to
evaluate and document the performance of reference and/or
contract laboratories at regularly defined intervals. Laboratories
must monitor, document and take appropriate action when
reference and/or contract laboratories fail to meet specified
criteria.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Analytic Systems ,"Fundamental Standard of Practice (AS
FS)
The laboratory must comply with Standards of Practice for Test
Procedure Content, Test Performance Specifications,
Calibration and Calibration Verification and Quality Control.
The laboratory must have testing and supporting standard
operating procedures. All procedures must accurately and
completely describe all activities required for the test process
and be in full compliance with requirements in the New York
State Clinical Laboratory Standards of Practice.
Statutory authority: Article 5, Title 5 Public Health Law
Sections 575(2) and (3)"
Test Procedure Content,,,,,,,,,
,,,,,,,,Test Procedure Content,"Standard of Practice 1 (TPC S1):
Test Procedure Content
For test procedures, required standard operating procedure
content must include:
a) implementation date for the current version of the test
procedure;
b) test purpose and intended use;
c) analytic principle of the test;"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,m) The test procedure may refer to separate policy documents.,,,,,,,,"d) biological, chemical and/or radiological safety;
e) specimen type, acceptable container(s), and if
applicable, minimum specimen quantity or volume
and/or required preservative;
f) requirements for patient preparation, specimen
collection, labeling, storage, preservation,
transportation, processing, and/or sending to a
reference or contract laboratory;
g) criteria for specimen acceptance and rejection that is
consistent with requirements in Specimen Processing
Standard of Practice 4;
h) storage of residual specimens and time limits for
requesting additional testing;
i) required equipment, instruments and reagents;
j) instrument and equipment function checks and
preventive maintenance;
k) test performance specifications for accuracy, precision,
reportable range, and analytical sensitivity and
specificity;
l) environmental requirements, including as needed, the
separation of incompatible activities and/or precautions
to mitigate specimen contamination;
m) actions to be taken if the laboratory is unable to perform
any part of the testing procedure;
n) steps required for testing, including, as appropriate:
i. preparation of slides, solutions, calibrators,
controls, reagents, stains and other materials"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,"n) ix. Panic or alert value summary lists may be posted if
under document control and where these values are
referenced in the clinical test procedure. For results that are
communicated verbally, a read back requirement should be
implemented to verify results.",,,,,,,,"used in testing;
ii. microscopic examination, including the detection
of inadequately prepared slides;
iii. calibration and calibration verification
procedures;
iv. quality control procedures that specify
acceptance and rejection criteria;
v. corrective action to be taken when quality
control or calibration verification fail to meet
acceptability criteria;
vi. calculations or evaluation criteria used to
determine test results;
vii. interpretation of test results;
viii. confirmatory, supplemental or additional testing,
if required;
ix. reporting results, including imminently life-
threatening results, or panic or alert values; and
o) reportable range for quantitative tests;
p) reference ranges, therapeutic or toxic concentrations, or
other interpretive criteria as appropriate to the test;
q) limitations of the test, including interfering substances
when applicable;
r) references to pertinent literature; and
s) any laboratory policy, service or additional requirements
as indicated in the New York State Clinical Laboratory
Standards of Practice."
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Testing procedures must be retained according to Document
and Specimen Retention Standard of Practice 3.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Three (3) separate rooms are recommended for nucleic acid
amplification assays. An alternative arrangement may be
developed within a room where reagent preparations (e.g.
mastermix set-up and template addition) are performed in
distinct areas.
a) does not apply to FDA-approved Closed System
Amplification Tests (CSATs). Individuals performing CSATs
may return to pre-amplification areas.
e) the remediation plan should: define the decontamination
procedure(s) to be employed; include root cause
investigation, corrective action, competency assessment
with retraining if necessary, and evidence supporting the
adequacy of the remediation/decontamination procedures
(e.g. environmental monitoring, increasing the number of
negative controls per run).",,,,,,,Test Procedure Content,"Standard of Practice 2 (TPC S2):
Test Procedures for Unidirectional Workflow
In addition to the requirements in Test Procedure Content
Standard of Practice 1, laboratories conducting target
amplification must have procedures to prevent nucleic acid
contamination that include:
a) unidirectional workflow from pre- to postamplification;
b) work area(s), personal protective equipment, and testing
materials dedicated to preamplification procedures;
c) work area(s), personal protective equipment, and testing
materials dedicated to postamplification procedures;
d) processes to prevent exposing specimens and
preamplification samples to amplification products; and
e) a decontamination and remediation plan to be
implemented in the event of contamination.
Testing procedures must be retained according to Document
and Specimen Retention Standard of Practice 3.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
Test Performance Specifications,,,,,,,,,
,,,,,,,,,"Test Performance Specification Standard of Practice 1
(TPS S1): Manufacturer Instructions
The laboratory must follow manufacturer instructions for FDA
approved, cleared or exempt instrument or test system
operation and control.
For FDA cleared, approved, or exempted methods used in
accordance with package inserts, at a minimum, the laboratory
must:
a) verify performance specifications for accuracy,
precision, and reportable range of test results
established by the manufacturer; and,
b) establish reference ranges, therapeutic or toxic
concentrations, or other interpretive criteria as
appropriate to the test.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Information on Departmental approval of a laboratory
developed test (LDT) is available at:
https://www.wadsworth.org/regulatory/clep/clinical-labs/obtain-
permit/test-approval.",,,,,,,,"Test Performance Specification Standard of Practice 2
(TPS S2): Laboratory Developed Tests
The laboratory must establish method performance
specifications before a test method is used to report specimen
results.
For laboratory developed tests (LDTs), modified FDA cleared,
approved, or exempted tests, and modifications to standard
methods (e.g., textbook methods), the laboratory must:"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"a) establish performance specifications for accuracy,
precision, reportable range, reference range(s),
analytical sensitivity and specificity (to include
interfering substances); clinical sensitivity and
specificity; and other applicable performance
characteristics;
b) determine the acceptability of the established
performance specification; and
c) adhere to LDT guidelines established by the
Department and submit required documents to the
Department for approval.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Information on Departmental approval of a laboratory
developed test (LDT) is available at:
https://www.wadsworth.org/regulatory/clep/clinical-labs/obtain-
permit/test-approval.",,,,,,,,"Test Performance Specification Standard of Practice 3
(TPS S3): Documentation
Method performance documentation must be available and
accessible and include:
a) the conclusion of the outcome of the performance
specification studies, including:
i. summary(ies) of data and performance
specifications as determined for Test
Performance Specification Standards of Practice
1 or 2;
ii. an attestation that the director or individual
delegated in writing by the director, has
approved the test, including a signature and the
approval date; and"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"b) a letter of Department approval, if required.
Documentation must be retained according to Document and
Specimen Retention Standard of Practice 8.
Regulatory authority: 10 NYCRR subdivision 58-1.11(c)(3)"
,"Mobile instruments and point-of-care devices need not be
verified in every possible site under the same New York State
permit.",,,,,,,,"Test Performance Specification Standard of Practice 4
(TPS S4): On-site Performance Specification Requirements
The laboratory must verify that results meet performance
specifications:
a) at the site where testing is performed, and must be
conducted by the laboratory’s test staff, in addition to
any on-site verification by the vendor;
b) after an instrument is moved or changes testing sites;
and
c) if the instrument will be hand-carried or otherwise
transported to the location of the specimen, the
laboratory must document the portability of the system.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Analysis of samples from patient specimens is preferred for
defining the relationship between test results. Specimens
should be selected to provide full-range assessment of
comparability.",,,,,,,,"Test Performance Specification Standard of Practice 5
(TPS S5): Comparability of Test Results
A laboratory that performs the same test using different
methods or instruments, and/or performs the same test at
multiple test sites under the same Permanent Facility Identifier
(PFI) must:"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,"a) The comparability study acceptability criteria may be
detailed in the QMS or standard operating procedures.",,,,,,,,"a) perform comparability studies as specified as part of the
Quality Management System (QMS);
b) establish acceptability criteria for comparing test results
and document the outcome of the comparison; and
c) compare test results semiannually at a minimum.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Calibration and Calibration Verification,,,,,,,,,
,"Information on Departmental approval of a laboratory
developed test (LDT) is available at:
https://www.wadsworth.org/regulatory/clep/clinical-labs/obtain-
permit/test-approval.
Data must be provided for the Department upon request,
including statistical analysis of the calibration and instrument
read outs.
If calibration proves less stable than the manufacturer’s
specification, more frequent calibration may be required.
NOTE: If reagents are obtained from a manufacturer and all of
the reagents for a test are packaged together, the laboratory is
not required to perform calibration for each package of
reagents, provided the packages of reagents are received in
the same shipment and contain the same lot.
For hematology cell counting instruments which have been
cleared or approved by the FDA and have not been modified by
the laboratory, the calibration verification requirements are
considered to be met if the laboratory follows the",,,,,,,,"Calibration Standard of Practice 1 (CAL S1): Calibration
Process and Documentation
The laboratory must determine, perform and document each
system’s calibration process for each test. The calibration
process must be included in the test procedure according to
Test Procedure Content Standard of Practice 1.
Unless otherwise indicated in the New York State Clinical
Laboratory Standards of Practice, the laboratory must perform
calibration:
a) according to manufacturer instructions, at a minimum,
using calibration materials provided or specified by the
manufacturer; or
b) according to laboratory developed test (LDT) criteria as
established for Test Performance Specification
Standard of Practice 2:
i. including the number, type and concentration of
calibration materials, acceptable limits for
calibration, and the frequency of calibration; and"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,"manufacturer’s instructions for operation and runs at least two
controls each day of testing.",,,,,,,,"ii. using calibration materials appropriate for the
methodology and, if possible, traceable to a
reference method or reference material of
known value.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Information on Departmental approval of a laboratory
developed test (LDT) is available at:
https://www.wadsworth.org/regulatory/clep/clinical-labs/obtain-
permit/test-approval.
For each quantitative test method or analytical system, the
laboratory should evaluate the stability of calibration and other
operating characteristics in establishing the calibration
verification schedule. Additional calibration materials should be
tested as unknowns to verify reportable range (upper, lower
and mid-range) of test results.
If the calibration is performed more frequently than six (6)
months using calibrators that span the reportable range, the
calibration verification requirements are met.
NOTE: If reagents are obtained from a manufacturer and all of
the reagents for a test are packaged together, the laboratory is
not required to perform calibration verification for each package
of reagents, provided the packages of reagents are received in
the same shipment and contain the same lot.
For hematology cell counting instruments which have been
cleared or approved by the FDA and have not been modified by
the laboratory, the calibration verification requirements are
considered to be met if the laboratory follows the
manufacturer’s instructions for operation and at least two",,,,,,,,"Calibration Standard of Practice 2 (CAL S2): Periodic
Calibration Verification
The laboratory must periodically perform and document
calibration verification procedures, minimally, according to
manufacturer’s instructions where provided, or according to
laboratory developed test (LDT) criteria established for Test
Performance Specification Standard of Practice 2, including:
a) the number, type and concentration of calibration
materials, acceptable limits for calibration verification
and frequency;
b) using calibration material appropriate for the method
and, if possible, traceable to a reference method or
reference material of known value; and verifying the
laboratory’s established reportable range of test results,
which shall include at least a minimal (or zero) value, a
mid-point value, and a maximum value at the upper limit
of that range; and,
c) at least every six (6) months, and when any of the
following occur:
i. a complete change of reagents for a procedure,
unless the laboratory can demonstrate that the
change does not affect the reportable range, and
control values are not adversely affected by"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,controls are run each day of testing.,,,,,,,,"reagent lot number changes;
ii. major preventive maintenance or replacement of
parts that may influence test performance;
iii. controls reflect an unusual trend or shift or are
outside the laboratory’s acceptable limits and no
other action can correct the problem; or
iv. the laboratory’s procedures require more frequent
calibration verification.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Quality Control,,,,,,,,,
,"Information on Departmental approval of a laboratory
developed test (LDT) is available at:
https://www.wadsworth.org/regulatory/clep/clinical-labs/obtain-
permit/test-approval.
For tests, such as certain staining procedures, for which no
controls are available, the laboratory should describe in their
standard operating procedure how to determine when the
expected reaction is not achieved.
Although a run may be defined as up to twenty-four (24) hours,
a laboratory that elects to perform all quality control at a fixed
time (e.g., start of the day shift) should demonstrate that the
system is stable throughout the twenty-four (24) hour period.",,,,,,,Quality Control ,"Standard of Practice 1 (QC S1): Minimum
Quality Control Requirements
Quality controls must be analyzed according to manufacturer
instructions or as described below, whichever is more stringent,
unless an Individualized Quality Control Plan (IQCP) is
established as described in Quality Control Standards of
Practice 2, 3 and 4. Category specific New York State Clinical
Laboratory Standards of Practice for quality controls that are
more stringent than manufacturer instructions or the
requirements below must be followed and are not eligible for an
IQCP.
At least once each day specimens are tested, the laboratory
must test quality controls as follows:
a) for qualitative tests, include a positive and negative
control;"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,"c) For semiquantitative tests: anti-streptolysin O titer and
antihyaluronidase titer tests do not require a negative
control; cold agglutination tests do not require a positive
control; radial immuno-diffusion tests require one control or
standard on each plate.
e) Inhibition controls may be excluded if there are sufficient
data showing that the inhibition rate is less than one (1)
percent for a specimen type for the assay. It is possible to
extend inhibition data to other analytes when applying the
same extraction procedure and specimen matrix and
utilizing the same amplification methodology. Inhibition
controls are not required if the run includes isolates only
and not patient specimens.
Negative controls, including template-free mastermix controls,
not only serve to identify technical and/or reagent issues, but
also help identify amplicon contamination. The negative
controls may include a reagent processing control that serves
as both a template-free mastermix reagent control as well as a
processing/extraction negative control. For laboratories
preparing mastermix to be used on multiple instruments, the
template-free mastermix control should be utilized for each run
of each instrument.
For infectious diseases molecular amplification procedures, the
positive control should be of a low but detectable amount. A
low-range positive is defined as having a value of not more
than ten (10) fold above the assay detection limit. For multiplex",,,,,,,,"b) for quantitative tests, include two (2) control materials of
different concentration suitable for error detection
throughout the reportable range;
c) for tests producing graded or titered results, include a
negative control material and a control material with
graded or titered reactivity, respectively;
d) for tests that include an extraction phase, include at
least one (1) control sample or material that is subjected
to the same extraction process as specimens and that
is capable of detecting errors in the extraction process;
or
e) for nucleic acid amplification methods:
i. include one (1) control capable of detecting
amplification inhibition by patient specimens
unless the Department approved laboratory
developed test (LDT) exempts the requirement;
and
ii. when more than one (1) outcome is possible at
a locus, include a control that represents each
outcome periodically.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,"assays, a low range control is required for each target. These
may be run on a rotating basis and may include pools of three
(3) to four (4) targets.",,,,,,,,
,"Additional information on IQCP requirements is available on the
CMS website.
The laboratory should refer to the following to conduct the risk
assessment: regulatory requirements; manufacturer package
insert, operator’s manual, troubleshooting guide, and bulletins;
laboratory-performed verification and establishment of
performance specifications data; testing personnel
qualifications, training and competency records; historical
quality control (QC) data; proficiency testing data; historical
quality assurance (QA) data; and scientific publications.
In laboratories with multiple numbers of identical devices (same
make and model), a single risk assessment may be performed
for the test system. When identical devices are utilized in
different environments/locations, the risk assessment must
consider this factor and the potential need for a customized
IQCP for the different sites.
a) to include historical testing data or validation data
performed by bona fide employees of the laboratory.
c) i. the following must be considered for the specimen:
patient preparation, specimen collection, labeling, storage,
preservation, stability, transportation, processing,
acceptability, rejection and referral.
c) ii. to include function and maintenance checks, inadequate
sampling, detection of interfering substances, mechanical
or electronic failures, system control and function checks
failures, software and/or hardware issues, transmission of",,,,,,,Quality Control ,"Standard of Practice 2 (QC S2):
Individualized Quality Control Risk Assessment
If the laboratory does not follow minimum quality control
requirements in Quality Control Standard of Practice 1, then a
risk assessment must be performed to determine if an
Individualized Quality Control Plan (IQCP) may be
implemented.
The documented risk assessment must, at a minimum:
a) identify and evaluate potential sources of error
associated with the test process based on testing
performed by a representative sampling of staff;
b) evaluate the frequency and impact of identified errors;
c) consider the potential errors that might be attributable to
the following components of the test process:
i. specimen (e.g., labeling, transportation, storage,
etc.);
ii. test system (e.g., interfering substances,
equipment failure/errors, etc.);
iii. reagent, quality control materials and calibrators
(e.g., shipment, storage, expired materials, etc.);
iv. environment (e.g., temperature, ventilation, dust,
etc.); and"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,"data to electronic systems including the laboratory
information system (LIS) or electronic health records (EHR),
and results reporting.
c) iii. to include preparation, stability, variability between lots,
intermixing of reagents from different lots.
c) iv. to include temperature, ventilation, light intensity, noise
and vibration, humidity, altitude, dust, water, utilities failure,
and adequate space.
c) v. to include education, licensure where required, training,
competency and adequate staffing levels.",,,,,,,,"v. staff (e.g., training, competency, staffing levels,
etc.).
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Additional information on IQCP requirements is available on the
CMS website.
Information on Departmental approval of a laboratory
developed test (LDT) is available at:
https://www.wadsworth.org/regulatory/clep/clinical-labs/obtain-
permit/test-approval.",,,,,,,Quality Control ,"Standard of Practice 3 (QC S3): Design of
an Individualized Quality Control Plan
If the laboratory chooses to perform quality control (QC) less
frequently than specified in Quality Control Standard of Practice
1, the laboratory must implement an Individualized Quality
Control Plan (IQCP) based on the risk assessment performed
according to Quality Control Standard of Practice 2.
The laboratory must establish and maintain an IQCP, as
described below, for any assay chosen by the laboratory in all
categories, excluding histopathology and cytopathology, that
verifies the intended quality of results is achieved prior to
reporting results.
The IQCP must include:
a) approval, including signature and date, by the
laboratory director or individual delegated in writing by
the director before implementation and following any
revisions;"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,"d) External QC refers to the use of control materials that are
not integrated into the design of the assay. This would
include control material purchased from a commercial
vendor or derived in-house. This is distinct from internal
QC, such as would be encountered in a single-use device
like an immunochromatographic cassette.",,,,,,,,"b) the process for performing QC, including:
i. the number, type and frequency of control
materials that must at least meet manufacturer’s
quality control instructions, when provided;
ii. the criteria for acceptable control results and
reporting of specimen data; and
c) data from the laboratory to support the process for
testing QC in (b) above;
d) requirements for testing external QC materials with
each:
i. change of reagent lot number;
ii. new shipment;
iii. change in storage conditions;
iv. replacement of a critical part; or
v. following any major preventive maintenance;
and
e) for a laboratory developed test (LDT), the laboratory
must submit quality control plans to the Department for
approval:
i. as part of a validation package for the addition of
a non-FDA-approved assay to the laboratory’s
test menu; or
ii. when the QC procedure is changed for an LDT
already approved by the Department; and
f) a process that ensures annual review and
documentation of review for effectiveness by the"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"director or an individual delegated in writing by the
director.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(3) and
subdivision 58-1.10(g)"
,"Additional information on IQCP requirements is available on the
CMS website.",,,,,,,Quality Control ,"Standard of Practice 4 (QC S4): Quality
Assessment Plan for Individualized Quality Control Plan
If an Individualized Quality Control Plan (IQCP) is developed
according to Quality Control Standard of Practice 3, the
laboratory must establish and maintain an IQCP Quality
Assessment Plan.
The IQCP Quality Assessment Plan must include:
a) approval, including signature and date, by the
laboratory director or individual delegated in writing by
the director before implementation and following any
revisions;
b) a system to monitor overall quality performance, to
include an assessment of the accuracy and precision of
test performance that may be influenced by changes in
test system stability, environmental conditions, or
variance in operator performance;
c) a process that defines the review and revision of the
quality control plan, as appropriate, when
nonconformances are identified; and
d) a process that ensures annual review and
documentation of review for effectiveness by the
director or an individual delegated in writing by the
director."
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Regulatory authority: 10 NYCRR paragraph 19.3(c)(3) and
subdivision 58-1.10(g)"
,,,,,,,,Quality Control ,"Standard of Practice 5 (QC S5): Control
Limits
Acceptability criteria for each lot or shipment of unassayed
control material must:
a) be established over time by the laboratory through:
i. concurrent testing with a control material having
previously determined ranges; or
ii. established as fixed limits based on analytical
system performance specifications around a
validated target value; and
b) reflect generally accepted medical and analytical
requirements for each analyte; and
c) be established prior to being placed into use.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(3) and
subdivision 58-1.10(g)"
,"The control material(s) may be verified concurrent with testing
of specimens, but results must not be reported until the
performance criteria have been verified.",,,,,,,Quality Control ,"Standard of Practice 6 (QC S6): Assayed
Value Verification
For each lot of assayed control material, the laboratory must
verify the:
a) assayed value prior to and/or concurrent with being
placed into use;
b) assayed value corresponds to the method and
instrument used; and"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"c) ranges reflect accepted medical and analytical
requirements for each analyte.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(3) and
subdivision 58-1.10(g)"
,,,,,,,,Quality Control ,"Standard of Practice 7 (QC S7): Calibration
Material Used as a Quality Control
Laboratories using a calibration material as a control must use
a calibration material from a different lot number than that used
to establish a cut-off value or used as calibration standards for
the test system.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(3) and
subdivision 58-1.10(g)"
,,,,,,,,Quality Control ,"Standard of Practice 8 (QC S8): Alternative
Means of Quality Control
A laboratory must use commercially prepared controls or
otherwise characterized materials if they are available.
Where quality control (QC) or calibration materials are not
available, the laboratory must describe in their test procedure,
according to Test Procedure Content Standard of Practice 1,
the QC process used to detect immediate errors and monitor
test performance over time. The acceptability criteria of
alternative control procedures must be documented in the test
procedure.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(4) and
subdivision 58-1.10(g)"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Quality Control ,"Standard of Practice 9 (QC S9): Control
Implementation
Laboratories must:
a) analyze controls using the number and frequency:
i. established under Quality Control Standard of
Practice 1;
ii. as required in any applicable category specific
New York State Clinical Laboratory Standard of
Practice; or
iii. following requirements established according to
Quality Control Standard of Practice 2, 3 and 4;
and
b) define and document the acceptability criteria of quality
control results.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"If a laboratory operates on multiple shifts, quality control
material shall be incorporated on other shifts on a regular
basis.
Rotation among testing personnel may be conducted, for
example, during annual competency assessments or after
calibration, or with the verification of new lots of materials.",,,,,,,Quality Control ,"Standard of Practice 10 (QC S10): Control
Routine Analysis
Quality control materials must be rotated among all testing
personnel, and to the extent possible, tested in the same
manner as patient specimens.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Where separation is based on both size and charge, running a
normal serum sample and an abnormal serum sample may be
adequate.",,,,,,,Quality Control ,"Standard of Practice 11 (QC S11):
Electrophoresis
For laboratories performing electrophoresis:"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"a) each electrophoretic cell or chamber must include at
least one (1) control sample containing fractions
representative of those routinely reported in specimens;
b) assays where the final product is assessed by product
size must, with every analysis:
i. include molecular weight markers of known size
that span the range of sizes routinely
encountered by the method;
ii. flanking size markers must be used with
sufficient frequency to perform accurate sizing;
and
c) a method must be established to verify that the transfer
from the gel to the membrane was complete.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"A threshold control contains a concentration of the analyte(s) of
interest that approximates the limit of detection or cut-off.",,,,,,,Quality Control ,"Standard of Practice 12 (QC S12): Thin
Layer Chromatography
For all compounds or groups of compounds identified by thin
layer chromatography, the laboratory must include for each test
batch and plate or card:
a) reference standards;
b) a negative control; and
c) a control with analyte concentration near the limit of
detection where control materials are processed
through the extraction phase of the analysis.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Quality Control ,"Standard of Practice 13 (QC S13): Control
Records
Records of actual results for each quality control must be
maintained by the laboratory, including:
a) quality control charts; and/or
b) other records which identify the controls by date and lot.
Actual measurements taken, reactions and /or observations
must be recorded, including if the results are acceptable.
“Check” marks are not sufficient to record acceptability unless
the definition of the checkmark is established in writing.
For tests in which results are reported in terms of graded
reactions (e.g., 1+, 2+, minimally reactive), the reaction grade
must be recorded.
Control records must be available for recreation of the test
process and when requested by the Department.
Regulatory authority: 10 NYCRR paragraph 58-1.11(c)(3)"
,,,,,,,,Quality Control ,"Standard of Practice 14 (QC S14): Control
Review
The laboratory must have a system for documented review of
quality control records that identifies shifts, trends or other
indicators of test instability.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Post-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Post-Analytic Systems,"Fundamental Standard of Practice
(PAS FS)
The laboratory must comply with Result Review, Reporting,
Public Health Reporting, and Confidentiality Standards of
Practice.
Compliance is required to ensure:
a) appropriate data review prior to release of test reports;
b) test reports are accurate;
c) that the laboratory complies with New York State public
health requirements, if applicable; and
d) confidentiality of patient information.
Statutory authority: Article 5, Title 5 Public Health Law
Sections 575(2) and (3)"
Result Review,,,,,,,,,
,,,,,,,,Result Review,"Standard of Practice 1 (RR S1): Result
Review Criteria
The laboratory must have standard operating procedures for
the review of test results for accuracy and reliability. Staff that
are responsible for result review must be specified in writing.
The laboratory must document the review of test results and
testing adherence to acceptability criteria.
Autoverification and subsequent release of examination results
is acceptable, provided the conditions and algorithms used"
Post-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"have been approved and signed by the director or an individual
delegated in writing by the director.
Review of all test results must verify that:
a) test results were produced with the required calibration
and/or quality control materials;
b) calibration and/or quality control data are acceptable
based on manufacturer requirements or laboratory
developed acceptability criteria;
c) test results are determined and/or calculated correctly;
d) dilution and other correction factors have been applied,
if needed;
e) specimen identification and associated results are
accurately linked and transcribed to the test report;
f) patient test results that are consistent with relevant
patient information such as age, gender, diagnosis, and
relationship are identified;
g) reference ranges are appropriate;
h) reporting interpretations are appropriate for the test
results; and
i) abnormal results are flagged, and alert or panic values
are communicated according to the laboratory’s
established standard operating procedures, protocols or
policies.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(4) and
subdivision 58-1.10(g)"
Post-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Acceptable differences or allowable discrepancies for specimen
test results may be determined based on the precision
observed for a control material at a similar analyte
concentration.",,,,,,,Result Review,"Standard of Practice 2 (RR S2): Acceptable
Differences for Replicate Analyses
The laboratory must have a policy to establish acceptable
differences when replicate analyses are performed on a
specimen, including:
a) requirements for retesting if the difference between
results is greater than the limits established by the
manufacturer’s instructions or the laboratory’s defined
acceptability criteria;
b) reporting policies (e.g., first value reported if differences
are acceptable, report the mean of two (2) values, etc.);
and
c) notification of clients if a value cannot be reported due
to unacceptable differences in results.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"The requirements of this standard are intended to be assessed
in concert with Investigation and Corrective Action Standards of
Practice 3, 4 and 5.",,,,,,,Result Review,"Standard of Practice 3 (RR S3):
Nonconformance Identification
During result review, any nonconformities identified as not
following the laboratory’s established standard operating
procedures or policies must be investigated.
Actions taken by the laboratory must include, but are not limited
to:
a) performing root cause analysis when a nonconformance
in the test process is identified and implement corrective
action(s), if required;"
Post-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"b) evaluating test results obtained since the last
acceptable testing to determine if results are inaccurate
or unreliable;
c) retesting specimens and notifying clients for any
reported results that are determined to be inaccurate or
unreliable;
d) releasing test reports only after corrective action has
been taken and documented to be effective; and
e) taking appropriate preventive action to ensure that
nonconformance does not recur.
The laboratory director or individual delegated in writing by the
director must document review of the investigation and
approval of any corrective action taken.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(4) and
subdivision 58-1.10(g)"
Reporting,,,,,,,,,
,"Supervisor qualified staff must verify that approved protocols
are routinely followed by technologists who have been
authorized to release results.
Electronic signatures must be password protected.",,,,,,,Reporting,"Standard of Practice 1 (REP S1): Authorized
Release of Test Results
The requirements to authorize release of test results must be
described in a standard operating procedure. The procedure
must define staff that are authorized to release test results, as
delegated in writing by the director. Standard operating
procedures for automated verification and release of results
must be approved by the director or individual delegated as
responsible in writing by the director.
In the categories of cytopathology and histopathology, only a
licensed pathologist, practicing in the state where they are"
Post-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"licensed, is authorized to release pathology reports, with the
exception of negative gynecological cytopathology reports
which may be released by a cytotechnologist.
Regulatory authority: 10 NYCRR section 58-1.3 and
subdivision 58-1.10(b) and (g)"
,,,,,,,,Reporting,"Standard of Practice 2 (REP S2): Test Report
Content
Test results must be available in a timely manner to the
authorized ordering source or client. Laboratories must be
capable of producing a hard copy of a laboratory report.
Test results, whether transmitted electronically or by hard copy,
must include all required report information, including:
a) patient name or other identification;
b) the name and address under which the reporting
laboratory has been issued a permit, unless the
laboratory has reported to the Department an
alternative name (e.g., “doing business as”);
c) the date, and hour if required, when the specimen was
collected;
d) the test report date;
e) specimen type and/or source (i.e., anatomic location),
when appropriate;
f) test results, and if applicable, units of measure,
reference ranges, or a similar method for identifying
abnormal values;"
Post-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"g) signature of the qualified person who reviewed,
approved and/or diagnosed the case, as required under
Reporting Standard of Practice 1; or
i. a record of the cytotechnologist releasing the
report is required for negative gynecological
cytopathology reports; and
h) a statement on the report if compromised specimens
are tested, the nature of the problem and, if applicable,
any impact on result interpretation;
i) if applicable, the name and address of the reference or
contract laboratory and the date the specimen was
tested or the date the result was reported;
j) any disclaimers or limitations to testing where required
by the Department for an approved laboratory
developed test (LDT);
k) any additional information required for the interpretation
of results; and
l) any other information as required in any part of the New
York State Clinical Laboratory Standards of Practice.
Regulatory authority: 10 NYCRR paragraph 58-1.11(b)(2)"
,,,,,,,,Reporting,"Standard of Practice 3 (REP S3): Reference and
Contract Laboratory Test Reports
Test results from a reference or contract laboratory must not be
revised or altered, including information related to the
interpretation of the result(s) provided by the testing laboratory."
Post-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Upon request of the authorized ordering source or client, a
reference or contract laboratory must make an exact duplicate
of their report available.
Regulatory authority: 10 NYCRR section 58-1.9"
,"Notification may be given to an agent of the authorized ordering
source.
This standard is not intended to address reports that are
amended to include additional findings.",,,,,,,Reporting,"Standard of Practice 4 (REP S4): Corrected
Reports
When errors or inaccuracies in test reports are detected, the
laboratory must:
a) promptly notify the authorized ordering source or client
of the reporting error(s);
b) promptly issue a report that identifies the corrected
information and clearly indicates the report as
corrected;
c) maintain the ability to generate the information
contained in the original report as well as the corrected
report to include:
i. the original report date;
ii. the corrected report date; and
d) maintain documentation to demonstrate the basis for
the change to the test report.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Post-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Reporting,"Standard of Practice 5 (REP S5): Timeliness
When the laboratory cannot report patient test results within its
established time frames, the laboratory must have a policy to
determine, based on the urgency of the patient test(s)
requested, the need to notify the appropriate individual(s) of the
delayed testing.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,,,,,,,,Reporting,"Standard of Practice 6 (REP S6): Alert Value
The laboratory must immediately alert the authorized ordering
source or client requesting the test and, if applicable, the
individual responsible for using the test results, when any test
result indicates an imminently life-threatening condition, or
panic or alert values, according to protocols established in Test
Procedure Content Standard of Practice 1.
The laboratory must document the date, time, test results and
person to whom the results were reported.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Public Health Reporting,,,,,,,,,
,"Additional information on reporting requirements are available
at: https://www.wadsworth.org/regulatory/clep/laws.
The testing laboratory is responsible for reporting except for
lead testing where the referring laboratory and the testing
laboratory may agree on which laboratory will report. Both
laboratories are accountable to ensure that a report is made.",,,,,,,Public Health Reporting,"Standard of Practice 1 (PHR S1):
Required Public Health Reporting
Laboratories must designate staff responsible for reporting
results on specimens originating from New York State that are
determined to meet any of the following:"
Post-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,"Laboratories must electronically report communicable disease
test results though the ECLRS module in the Health Commerce
System (HCS).
Heavy Metals Registry reporting may be done electronically
through ECLRS or by paper.
For additional information, see Department websites for
Communicable Disease Reporting, the Heavy Metals Registry
and the Cancer Registry.",,,,,,,,"a) infectious diseases as required in Title I Section 2102
for communicable disease reporting, including all
SARS-CoV-2 test results;
b) cases of initial determination or diagnosis of HIV
infection, HIV-related illness and AIDS as required in
Subpart 63.4;
c) results of all blood lead analyses with demographic data
as required in Subpart 67-3;
d) all elevated levels of reportable metal as provided in
Title 10 sections 22.6 and 22.7;
e) every case of cancer, brain tumor, or other malignant
disease as provided in Title I sections 2400-2404; and
f) test results indicative of pesticide exposure, such as
blood cholinesterase levels and levels of pesticides in
human tissue specimens which exceed the normal
range established by the laboratory, as required under
Part 22 of Chapter 1 of the State Sanitary Code.
In addition, an annual Blood Services Activity report is required
from blood banks and transfusion services as required under
10 NYCRR section 58-2.10.
Regulatory authority: as noted and 10 NYCRR paragraph
19.3(c)(2)"
,"For specific communicable diseases and additional information,
see Communicable Disease Reporting Guidelines at:
https://www.wadsworth.org/regulatory/clep/laws.",,,,,,,Public Health Reporting,"Standard of Practice 2 (PHR S2):
Communicable Disease Confirmation
New York State Public Health Law Section 576-c (4) and Article
11 of the New York City Health Code require confirmatory
testing of isolates for communicable diseases."
Post-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"For specimens that are suspected or reported as confirmed
positive for communicable diseases, the testing laboratory must
submit isolates for confirmatory testing in accordance with the
Communicable Disease Reporting Guidelines.
Statutory authority: as noted"
Confidentiality,,,,,,,,,
,"Special attention should be given to confidentiality training of
employees of patient service centers and other patient contact
areas of the laboratory.",,,,,,,Confidentiality,"Standard of Practice 1 (CON S1):
Confidentiality Training
The laboratory must ensure that protected health information
regarding patients is kept confidential throughout all phases of
the total testing process that are under the laboratory's control.
The laboratory must have a policy to educate staff on protected
health information. At a minimum, confidentiality training must
be done as part of initial employee training, and annually
thereafter.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Employees who may have contact with confidential information
should sign an attestation statement, which documents training
on the laboratory’s confidentiality policy, applicable statutes
and regulations, and acknowledgment of the consequences of
violation, which may include criminal prosecution.",,,,,,,Confidentiality,"Standard of Practice 2 (CON S2):
Confidentiality Protocol
The laboratory must establish policies and protocols to ensure
that protected health information remains confidential. The
policies and protocols must include:
a) a prohibition of access or disclosure unless approved by
the director to perform duties; and
b) responsibilities of all employees and agents to ensure
that:"
Post-Analytic Systems,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"i. confidential information is accessible only to
authorized persons;
ii. confidential information, if stored, is secure;
iii. only information necessary to fulfill authorized
functions is maintained in the laboratory units;
iv. confidential information is secured from casual
observation;
v. confidential information is released or transferred
only as authorized by the director, subject to New
York State and federal confidentiality
requirements;
vi. obsolete information is purged or destroyed in an
appropriate manner; and
vii. proper behavior is exhibited showing no
discrimination, abuse or other adverse actions
directed at any patient or client.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,"Laws and regulations pertaining to HIV-related and genetic
testing information and information on their applicability to
testing performed at the laboratory should be available to
employees.",,,,,,,Confidentiality,"Standard of Practice 3 (CON S3): Controlled
Records Access
The director is responsible for determining and approving:
a) the circumstances and duties where access to
confidential information is appropriate for staff; and
b) how, and to whom, information is to be released,
subject to state and federal confidentiality requirements.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Document and Specimen Retention,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Document and Specimen Retention ,"Fundamental Standard
of Practice (DSR FS)
The laboratory must comply with Document and Specimen
Retention requirements as indicated in any part of the New
York State Clinical Laboratory Standards of Practice.
Documents must be retained for recreation of the test process
and to substantiate test report findings.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576"
,,,,,,,,Document and Specimen Retention ,"Standard of Practice 1
(DSR S1): Quality Assurance Records
All manuals, standard operating procedures, policies and
documents related to the laboratory’s Quality Management
System (QMS) and quality assurance activities must be
retained for a minimum of two (2) years, unless otherwise
indicated below.
Documentation that must be retained includes, but is not
limited to:
a) internal systems and process audits, and external
inspection documents, including:
i. who conducted the audit;
ii. the dates of the audit;"
Document and Specimen Retention,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"iii. audit findings and any actions taken;
iv. for the category of forensic identity, all audit
records must be retained for three (3) years and
according to Forensic Identity Standard of
Practice 29; and
b) complaints, investigations related to complaints and, if
applicable, corrective action(s) associated with
Investigation and Corrective Action Standards of
Practice 1;
c) nonconformances and related documents associated
with Investigation and Corrective Action Standard of
Practice 2;
d) corrective action documents associated with
Investigation and Corrective Action Standard of Practice
4:
i. for the category of forensic identity, laboratories
must retain corrective action records for three
(3) years and according to Forensic Identity
Standard of Practice 28; and
e) review of the effectiveness of corrective actions
associated with Investigation and Corrective Action
Standard of Practice 5.
Regulatory authority:10 NYCRR subdivision 58-1.2(c)"
,,,,,,,,Document and Specimen Retention ,"Standard of Practice 2
(DSR S2): Human Resources, Training and Competency
Records
The laboratory must retain human resources, training and"
Document and Specimen Retention,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"competency records for the duration of employment and six (6)
years thereafter, unless otherwise indicated below, including:
a) relevant licensure;
b) educational and professional qualifications;
c) dates of employment;
d) job descriptions;
e) training:
i. with the exception of safety training which must
be retained for three (3) years.
f) competency assessments; and
g) continuing education.
Regulatory authority: 10 NYCRR Subdivision 58-1.2(d)"
,"Transfusion and blood services regulations (10 NYCRR
paragraph 58-2.8(a)(9)) require that discontinued procedures
be retained for at least seven (7) years.",,,,,,,Document and Specimen Retention ,"Standard of Practice 3
(DSR S3): Controlled Document Retention
Unless a longer retention time is required in another part of the
New York State Clinical Laboratory Standards of Practice or
elsewhere in regulation, the laboratory must retain controlled
documents, including test procedures developed according to
Test Procedure Content Standards of Practice 1 and 2, for the
duration of use and two (2) years after discontinuation or
archival.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Document and Specimen Retention,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Document and Specimen Retention ,"Standard of Practice 4
(DSR S4): Laboratory Information System Records
Retention
The laboratory must retain laboratory information system (LIS)
records for two (2) years including records related to:
a) validation of system changes, including new or revised
software and/or hardware prior to their use for specimen
testing, reporting and record keeping functions; and
b) system maintenance required by the LIS manufacturer,
or established and validated by the laboratory, including
the environmental and operating conditions necessary
to maintain the integrity of data.
Regulatory authority: 10 NYCRR subdivision 58-1.2(c)"
,"The minimum retention period for the supplies inventory
records is two (2) years; the laboratory management may
define any length of storage greater than two (2) years.",,,,,,,Document and Specimen Retention ,"Standard of Practice 5
(DSR S5): Verification Records
The laboratory must retain records on verification of supplies,
equipment and instruments, and reagents and media for the
duration of use and two (2) years after discontinuation.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
,,,,,,,,Document and Specimen Retention ,"Standard of Practice 6
(DSR S6): Monitoring, Maintenance and Preventive
Maintenance Records
The laboratory must retain records for:"
Document and Specimen Retention,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"a) environmental monitoring performed according to
Facility Design Standard of Practice 2, including
monitoring of temperature-controlled spaces, for two (2)
years; and
b) maintenance and preventive maintenance records
generated according to Laboratory Equipment and
Instrument Standard of Practice 3, including service and
repair records, for as long as the instrument remains in
use and two (2) years following discontinuation of use.
Regulatory authority: 10 NYCRR paragraphs 58-
1.11(c)(2),(3),(4)"
,,,,,,,,Document and Specimen Retention ,"Standard of Practice 7
(DSR S7): Test Request and Specimen Processing
Documents
The following records must be retained for at least the period
specified, except where other New York State or federal
regulations or statutes require retention for different periods of
time, the laboratory must retain the appropriate record for the
longest period applicable.
The laboratory must retain:
a) test request documentation associated with Test
Request Standards of Practice for the same period of
time as required for the test report for a specific
category or seven (7) years, whichever is less, with the
exception of information for cytogenetic cases that must
be retained for six (6) years; and"
Document and Specimen Retention,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"b) accession records associated with Specimen
Processing Standards of Practice for seven (7) years.
Regulatory authority: 10 NYCRR paragraphs 58-1.11(c)(1)
and (2)"
,,,,,,,,Document and Specimen Retention ,"Standard of Practice 8
(DSR S8): Analytic System Records Retention
Analytic system records must be retained by the laboratory, as
follows:
a) performance specification data and records of
acceptability criteria that the laboratory establishes or
verifies under Test Performance Specification
Standards of Practice 1 and 2 must be retained for as
long as the laboratory uses the test process, plus two
(2) years after discontinuation:
b) testing records, including but not limited to worksheets
containing instrument readings, the identity of staff who
performed the test(s), and raw patient results, must be
retained for two (2) years; Next Generation Sequencing
(NGS) FASTQ files or equivalent; and in the category of
cellular immunology, electronic flow cytometer data in
listmode or equivalent format, must be retained for two
(2) years;
c) result review records, including acceptability of quality
control and calibration materials for two (2) years:
d) histogram of an automated differential result for two (2)
years; and"
Document and Specimen Retention,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"e) a record of the purity of all drug standard(s) for the
period they are in use, and for two years thereafter for
forensic toxicology.
Regulatory authority: 10 NYCRR paragraphs 58-
1.11(c)(2),(3),(4)"
,"Off-site or electronic storage systems are acceptable, provided
the laboratory can produce records within twenty-four (24)
hours of a request.
Original electronic data must be maintained as long as the
case file and must be protected from loss or modification.",,,,,,,Document and Specimen Retention ,"Standard of Practice 9
(DSR S9): Report Retention
All reports of tests performed, including the original or
duplicates of original reports received from another laboratory,
must be kept on the premises of both laboratories.
Reports must be produced for the Department upon request
and be retained by the laboratory for:
a) tissue pathology including exfoliative cytology for twenty
(20) years;
b) syphilis serology negative report for two (2) years;
c) cytogenetics for twenty-five (25) years and according to
Cytogenetics Standard of Practice 14;
d) case files for forensic identity investigations and
electronic data for fifteen (15) years and according to
Forensic Identity Standard of Practice 19; and
e) all others for seven (7) years.
Regulatory authority: 10 NYCRR paragraph 58-1.11(c)(5)"
Document and Specimen Retention,,,,,,,,,
,Guidance,,,,,,,,Standard
,"For specimens not addressed in this Standard, the laboratory
director may determine an appropriate retention time.
a) i and ii. A routine blood film is one where no abnormal cells
or cell counts are observed, or where a blood disorder is
not indicated.
a) A routine histogram of an automated differential is one that
results as “normal” or “negative” and does not imply the
need for further analysis. Histograms are considered to be
an instrument printout and must therefore be retained,
electronically or as hard copy, for two (2) years as required
in Document and Specimen Retention Standard of Practice
8. It is not required for a laboratory to create or maintain
routine blood films if such films are not routinely generated
in accordance with the laboratory’s approved procedures.
c) i. and ii. include gynecological, non-gynecological, and fine
needle aspirate (FNA) for cytopathology.
f) i. and ii. Slides or electronic images that allow re-evaluation
of the entire slide(s) used for reported results.
i) Recipient refers to any person receiving blood or blood
components.",,,,,,,Document and Specimen Retention ,"Standard of Practice
10 (DSR S10): Specimen Retention
Laboratories must be able to retrieve specimens within twenty-
four (24) hours. Specimens must be retained, as follows:
a) blood films:
i. routine, for six (6) months;
ii. other than routine, for one (1) year;
b) bacteriology slide on which a diagnosis depends, for
one (1) year;
c) cytology slide showing:
i. no abnormality, for five (5) years;
ii. any abnormality, for ten (10) years;
d) tissue block for twenty (20) years;
e) pathology tissue remnants, until a diagnosis is made;
f) histopathology:
i. block, for twenty (20) years;
ii. slide, for twenty (20) years;
g) bone marrow biopsy, for twenty (20) years;
h) cytogenetic slide, for six (6) years;
i) recipient blood specimens, for one (1) week stoppered
at one (1) to six (6) degrees Celsius;
j) samples of each unit of transfused blood, for seven (7)
days for further testing in the event of a transfusion"
Document and Specimen Retention,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"reaction;
k) forensic toxicology specimens that were reported as
positive, adulterated, substituted or invalid for a
minimum of one (1) year and according to Forensic
Toxicology Standard of Practice 34; and
l) mycobacteriology:
i. all original and subsequent M. tuberculosis
complex isolates from all patients, for one (1)
year and according to Mycobacteriology
Standard of Practice 13; and
ii. stained slides of direct smears from primary
specimens, until the final culture report has been
issued and according to Mycobacteriology
Standard of Practice 9.
Regulatory authority: 10 NYCRR paragraph 58-1.11(d)(1)"
,,,,,,,,Document and Specimen Retention ,"Standard of Practice
11 (DSR S11): Proficiency Testing Records Retention
A laboratory must maintain all records generated during the
test process for proficiency testing samples, including test
reports.
All documentation of review, investigation, corrective action,
nonconformance, or other documentation related to proficiency
testing, must also be retained.
Records must be retained for a minimum of two (2) years from
the date of the proficiency test for all categories except:"
Document and Specimen Retention,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"a) forensic identity, which requires three (3) years and
according to Forensic Identity Standard of Practice 26;
and
b) immunohematology, which requires five (5) years.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,,,,,,,,Document and Specimen Retention ,"Standard of Practice
12 (DSR S12): Laboratory Closure
The laboratory director and owner are jointly responsible for
notifying the Department if the laboratory ceases operation.
The laboratory director and owner are jointly and separately
responsible for ensuring that all records and, as applicable,
slides, blocks, and tissue, are retained and available for the
time frames specified in this section. The laboratory must
inform the Department and former clients as to where such
records and specimens are maintained.
Regulatory authority: 10 NYCRR subdivision 58-1.10(g)"
Proficiency Testing,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Proficiency Testing ,"Fundamental Standard of Practice (PT
FS)
All permitted laboratories must meet New York State and
federal proficiency test requirements. Failure to comply with
New York State Standards and federal regulation may result in
sanctions being brought against laboratories under state and
federal regulations.
For each analyte performed, in all categories held on the
permit, the laboratory is responsible for establishing, monitoring
and maintaining the:
a) accuracy and reliability of test results through
participation in proficiency testing; and/or
b) alternative assessment of test performance.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,"Please see 42 CFR §493.801 for federal Proficiency Testing
regulations.
Information on Department notification and annual Proficiency
Testing enrollment is available in the PT Guide and on our
website and available at:
https://www.wadsworth.org/regulatory/clep/pt.
Participation in proficiency testing is recommended for all tests
not included in Subpart I, if a formally evaluated program is
available.",,,,,,,Proficiency Testing ,"Standard of Practice 1 (PT S1):
Enrollment, Department Notification and Participation
For each category, subcategory and analyte designated as
New York State mandated in the Clinical Laboratory Evaluation
Program Proficiency Testing Guide, laboratories must:
a) enroll in a New York State approved and mandated
proficiency testing program;"
Proficiency Testing,,,,,,,,,
,Guidance,,,,,,,,Standard
,"When laboratories use more than one method to determine
results for a given analyte, only the primary method should be
evaluated using proficiency testing. Secondary methods must
be assessed as outlined in Test Performance Specification
Standard of Practice 5.",,,,,,,,"b) notify the Department on an annual basis, in a manner
prescribed by the Department, of proficiency testing
program(s) to be used to fulfill these requirements;
c) successfully participate in proficiency testing using their
primary method of analysis.
Once enrolled with a proficiency testing program to fulfil this
requirement, the laboratory must participate with the same
program until the end of the calendar year.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,"Participation in proficiency testing is recommended for all tests
not included in Subpart I, if a formally evaluated program is
available.",,,,,,,Proficiency Testing ,"Standard of Practice 2 (PT S2):
Authorized Release of Proficiency Testing Results
The laboratory must authorize the proficiency test provider to
release all proficiency testing grades and/or results to the
Department, in a manner prescribed by the Department.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,"Information on New York State PT requirements is available at:
https://www.wadsworth.org/regulatory/clep/pt.
The laboratory may evaluate the accuracy of testing through
testing of: split-samples (specimens and/or quality control
samples) with another validated method; blind testing of
specimens with known results; or other equivalent system.
Participation in proficiency testing is recommended for all tests
not included in Subpart I, if a formally evaluated program is
available.",,,,,,,Proficiency Testing ,"Standard of Practice 3 (PT S3):
Alternative to Proficiency Testing
Laboratories must have standard operating procedures to
verify the reliability and accuracy of test results for:
a) New York State mandated analytes for which there is
no commercially-available proficiency testing; and
b) tests/analytes that are not listed in 42 CFR 493 subpart
I for which:"
Proficiency Testing,,,,,,,,,
,Guidance,,,,,,,,Standard
,"When laboratories use more than one method to determine
results for a given analyte, only the primary method is required
to be assessed twice per year per this standard. Secondary
methods must be assessed against the primary method as
outlined in Test Performance Specification Standard of Practice
5.",,,,,,,,"i. the laboratory does not participate in
commercially-available proficiency testing; or
ii. proficiency testing is not available.
Test reliability and accuracy assessment must be conducted at
least semiannually and according to Proficiency Testing
Standard of Practice 10.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(4) and
subdivision 58-1.10(g)"
,"Proficiency test samples must be accessioned and handled as
much like patient specimens as possible, with the exception of
automatic reflex testing to another laboratory.
The highest level of organism identification means the highest
level of identification performed and resulted by the laboratory
for patient specimens for the organism identified.",,,,,,,Proficiency Testing ,"Standard of Practice 4 (PT S4): Routine
Analysis
Unless instructed otherwise by the proficiency testing provider,
laboratories must use the same test process for proficiency
testing samples that is used for patient specimens.
Proficiency testing samples must be:
a) incorporated into the laboratory’s routine workflow; and
b) rotated among all operators that perform testing;
c) in microbiology, reported to the highest level of
organism identification performed by the laboratory.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,"Proficiency test samples must not be used for other purposes
(e.g., competency testing) until after the date the laboratory is
required to report the proficiency test results to the proficiency
test provider.",,,,,,,Proficiency Testing ,"Standard of Practice 5 (PT S5):
Repeated Analysis
Laboratories must not repeatedly analyze proficiency testing
samples unless patient specimens are routinely tested this
way."
Proficiency Testing,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,"Whenever the Department finds evidence that a laboratory has
misrepresented its proficiency through referral of proficiency
test samples and/or interlaboratory communication, resulting in
submission of results generated elsewhere or generated in
collusion, the laboratories are subject to enforcement sanctions
under Section 577 of Article 5, Title 5, which include revocation
of laboratory permit and director certificate of qualification.",,,,,,,Proficiency Testing ,"Standard of Practice 6 (PT S6):
Interlaboratory Communication
Laboratories, including laboratories with multiple testing sites or
separate locations, must not engage in interlaboratory
communication or discussions related to the results of
proficiency testing samples until after the date the laboratories
are required to report the results to the proficiency test
provider.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,"Whenever the Department finds evidence that a laboratory has
misrepresented its proficiency through referral of proficiency
test samples and/or interlaboratory communication, resulting in
submission of results generated elsewhere or generated in
collusion, the laboratories are subject to enforcement sanctions
under Section 577 of Article 5, Title 5, which include revocation
of laboratory permit and director certificate of qualification.",,,,,,,Proficiency Testing ,"Standard of Practice 7 (PT S7):
Proficiency Testing Sample Referral
Laboratories must not send proficiency test samples or share
portions or aliquots of proficiency testing samples with any
other laboratory until after the date the laboratories are
required to report the results to the proficiency test provider.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,,,,,,,,Proficiency Testing ,"Standard of Practice 8 (PT S8):
Proficiency Testing Referral Notification
The laboratory must have a standard operating procedure or
policy that prohibits proficiency testing sample referral to, and
acceptance from, other laboratories."
Proficiency Testing,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Laboratories must notify the Department within seventy-two
(72) hours if samples are received or identified as proficiency
testing samples from another laboratory.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,"The summary page(s) generated by online results submission,
signed by the required personnel, fulfills this requirement.
These documents will be reviewed during the on-site survey.",,,,,,,Proficiency Testing ,"Standard of Practice 9 (PT S9):
Attestation
The proficiency test provider’s attestation statement must be
signed by the:
a) laboratory director or individual delegated in writing by
the director as responsible; and
b) analyst(s) performing the test.
The signed document must be kept on file in the laboratory for
review by the Department during on-site survey.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,"This standard applies to all proficiency tests, alternatives to
proficiency testing, and educational analytes/events.",,,,,,,Proficiency Testing ,"Standard of Practice 10 (PT S10):
Performance Review – All Results
The laboratory director or staff delegated in writing by the
director, must review and document evaluation:
a) of all proficiency testing results;
b) of any results produced as an alternative to proficiency
testing to fulfill the requirements of Proficiency Testing
Standard of Practice 3; and"
Proficiency Testing,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"c) within two (2) weeks of proficiency testing results
becoming available from the provider or completing the
alternative assessment.
For proficiency testing, an individual analyte score and, when
applicable, overall event testing score, must be reviewed.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,"This standard applies to all proficiency tests and alternatives to
PT.",,,,,,,Proficiency Testing ,"Standard of Practice 11 (PT S11):
Result Investigation
The laboratory must perform root cause analysis for all
proficiency testing results and any results produced as an
alternative to proficiency testing when:
a) the score received in a proficiency testing program is
less than one hundred (100) percent;
b) results do not meet the laboratory’s specified
performance criteria; and/or
c) shifts and trends are identified.
The laboratory director or assistant director responsible for the
category must document review of the investigation.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,,,,,,,,Proficiency Testing ,"Standard of Practice 12 (PT S12):
Unsatisfactory and Unacceptable Performance – Remedial
Action
The laboratory must implement and document corrective
action(s), if needed, when an unsatisfactory or unacceptable"
Proficiency Testing,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"proficiency testing (PT) or alternative assessment result is
identified.
Laboratories that demonstrate unsatisfactory or unacceptable
performance must:
a) identify impacted patient results based on the root
cause analysis of the unsuccessful or unsatisfactory PT
performance investigation performed according to
Proficiency Testing Standard of Practice 11; and
b) notify clients and issue corrected reports for reported
results that are determined to be inaccurate or
unreliable.
The laboratory director or staff delegated as responsible in
writing by the director must document review and approval of
any corrective action taken.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,"Laboratories may perform one (1) out of sequence event per
year if the out of sequence event is supplied by the PT provider
designated by the laboratory.",,,,,,,Proficiency Testing ,"Standard of Practice 13 (PT S13):
Unsuccessful Performance – Remedial Action and
Continued Specimen Testing
Laboratories that are notified by the Department of
unsuccessful performance in proficiency testing must:
a) identify a New York State permitted laboratory to refer
patient specimens to for testing, in the event that patient
testing is voluntarily stopped;
b) immediately perform root cause analysis to identify the
root or contributing cause(s) of the deficiency to include"
Proficiency Testing,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"what happened, why and how the nonconformity
occurred, when it began and who was involved;
c) describe the impact of the nonconformity on results;
d) notify clients and issue corrected reports for reported
results that are determined to be inaccurate or
unreliable;
e) report findings to the Department within the specified
time period of notification of unsuccessful performance:
i. failure to report the results of the investigation
and plan of correction to the Department within
ten (10) business days, or when the plan of
correction is deemed unacceptable by the
Department, will result in a cease testing
directive being issued by the Department; and
f) demonstrate the effectiveness of the corrective action
through successful performance in two (2) consecutive
proficiency test events.
The laboratory director or assistant director responsible for the
category must document review of the investigation and
approval of any corrective action taken.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,,,,,,,,Proficiency Testing ,"Standard of Practice 14 (PT S14):
Unsuccessful Performance – Cessation of Specimen
Testing
The laboratory must cease testing of clinical specimens for a
minimum of six (6) months upon unsuccessful performance in"
Proficiency Testing,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"proficiency testing and in the event that the Department
determines that any of the following conditions exist:
a) immediate jeopardy to patient health or safety;
b) the laboratory fails to provide satisfactory evidence that
it has taken steps to correct the problem(s) identified
during remedial action of the unsuccessful proficiency
testing performance, according to the requirements for
Proficiency Testing Standard of Practice 13;
c) the root cause(s) of unsatisfactory performance are
systemic to laboratory practices;
d) the laboratory has demonstrated a history of non-
compliance with standards of good laboratory practice;
or
e) the Department determines that the laboratory has
demonstrated a pattern of poor performance, including
unsatisfactory performance over three (3) of five (5)
consecutive test events for the same analyte, category
or subcategory.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
,"Subsequent to enforcement for ceased patient testing for six
(6) months, reinstatement of testing approval is considered
only if the laboratory is fully compliant with requirements under
Proficiency Testing Standard of Practice 13.",,,,,,,Proficiency Testing ,"Standard of Practice 15 (PT S15):
Unsuccessful Performance – Department Enforcement
Where performance in proficiency testing provides evidence of
risk for patient harm as judged by criteria a-e under Proficiency
Testing Standard of Practice 14, and the laboratory does not
comply with the Department’s directive to cease testing, the
Department will take enforcement action as authorized by
Sections 576(3) and 577 of Public Health Law, Article 5, Title 5,"
Proficiency Testing,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"seeking limitation of the laboratory’s permit in the area of failure
for a minimum of six (6) months.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3) and 577"
,,,,,,,,Proficiency Testing ,"Standard of Practice 16 (PT S16):
Proficiency Testing Documentation
Laboratories must maintain the following documentation of the
processing and reporting of proficiency testing samples:
a) steps taken in handling, preparing, processing,
examining, testing and reporting all results in the
proficiency test event;
b) the proficiency testing provider’s attestation form
completed in accordance with the provider’s instructions
and requirements; and
c) copies of all testing records, including copies of the
proficiency test report forms that must be retained
according to Document and Specimen Retention
Standard of Practice 11.
Statutory authority: Article 5, Title 5 Public Health Law
Section 576(3)"
Investigation and Corrective Action,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,Investigation and Corrective Action ,"Fundamental Standard
of Practice (ICA FS)
The laboratory must comply with the Standards of Practice
provided in this section. The laboratory must follow established
procedures, address nonconformances when appropriate, and
evaluate the effectiveness of corrective actions.
Statutory authority: Article 5, Title 5, Public Health Law
Sections 575(2) and (3)"
,,,,,,,,Investigation and Corrective Action ,"Standard of Practice 1
(ICA S1): Complaint Investigation and Resolution
The laboratory must have a standard operating procedure to
address and resolve complaints or other communications
received from staff, clients, and/or any outside sources or
entities. The procedure must describe requirements for:
a) documentation:
b) criteria for complaint investigation; and
c) actionable events requiring nonconformance
investigation and corrective action."
Investigation and Corrective Action,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"Regulatory authority: 10 NYCRR paragraph 19.3(c)(5) and
subdivision 58-1.2(c)"
,,,,,,,,Investigation and Corrective Action ,"Standard of Practice 2
(ICA S2): Procedure and Documentation for Control of
Nonconformities
The laboratory must have a standard operating procedure
describing actions taken when laboratory services do not follow
an established policy and/or standard operating procedure,
requirements of the Quality Management System (QMS) or
client specifications.
All nonconformities must be documented and ensure that:
a) personnel responsible for problem resolution are
designated;
b) appropriate steps to be followed are defined;
c) the clinical significance of the nonconforming laboratory
service is considered, and where appropriate, the
authorized ordering source or client is informed;
d) testing is suspended, and reports withheld as
necessary;
e) corrective action and root cause analysis are initiated at
the time the nonconformance is identified;
f) any released test results associated with nonconforming
laboratory services are identified and recalled or
corrected, if necessary;
g) steps to be taken to resume testing and authorization"
Investigation and Corrective Action,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"for resumed testing are defined; and
h) each episode of nonconformity is documented,
recorded and reviewed at regular specified intervals as
defined in the standard operating procedures to detect
trends and initiate preventive action(s).
Regulatory authority: 10 NYCRR paragraph 19.3(c)(5) and
subdivision 58-1.2(c)"
,,,,,,,,Investigation and Corrective Action ,"Standard of Practice 3
(ICA S3): Actionable Events
The laboratory must define a nonconformity to include any
aspect of the test process that does not follow the laboratory’s
established standard operating procedure and/or policies,
requirements of the Quality Management System (QMS) or
client specifications including:
a) when the criteria for proper storage of reagents and
specimens are not met; or
b) supplies are insufficient or not available for testing; or
c) equipment, instruments or testing that perform outside
of established operating parameters or performance
specifications, as evidenced by:
i. unacceptable results or performance;
ii. unacceptable differences in test results between
different instruments or with the same test
performed at multiple testing sites; or"
Investigation and Corrective Action,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"d) when results of quality control and/or or calibration
materials fail to meet the laboratory’s established
acceptability criteria; or
e) specimen results outside of the laboratory’s reportable
range for the test procedure indicate that the test is not
performing according to the laboratory’s defined
performance specifications; or
f) reference ranges for a test procedure are inappropriate
for the laboratory’s test population.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(5) and
subdivision 58-1.2(c)"
,,,,,,,,Investigation and Corrective Action ,"Standard of Practice 4
(ICA S4): Corrective Action Procedure and Documentation
The laboratory must have a standard operating procedure
describing the process for initiating corrective actions that are
appropriate to the magnitude of the problem and
commensurate with the risks encountered.
For corrective actions, the laboratory must:
a) perform root cause analysis to identify underlying
cause(s) of a nonconformance;
b) initiate and document corrective actions and, where
appropriate, preventive actions;
c) document and implement any policy and/or standard
operating procedure changes required for corrective
actions, if applicable;"
Investigation and Corrective Action,,,,,,,,,
,Guidance,,,,,,,,Standard
,,,,,,,,,"d) assess the results of any corrective actions taken to
ensure that they have been effective;
e) ensure that noncompliant practices are not occurring in
other sections/categories of the laboratory; and
f) submit the results of corrective actions to the laboratory
director or individual designated in writing by the
director for documentation of review.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(5) and
subdivision 58-1.2(c)"
,,,,,,,,Investigation and Corrective Action ,"Standard of Practice 5
(ICA S5): Corrective Action Effectiveness
After implementation of a corrective action, preventive action,
or improvement, the laboratory must evaluate and document
an assessment of effectiveness.
Regulatory authority: 10 NYCRR paragraph 19.3(c)(5) and
subdivision 58-1.2(c)"
Section or Category,,,Abbreviation,,,Standard title,,,
,,TPC S1,,,Test Procedure Content,,,,General Systems
,,TPC S2,,,Test Procedures for Unidirectional Workflow,,,,General Systems
,,LBS S2,,,Procedure,,,,Laboratory Blood Services
,,CI S9,,,Antibody Fluorochrome Stability,,,,Cellular Immunology
,,CI S13,,,Event Collection Procedure,,,,Cellular Immunology
,,LF S6,,,"Function Quality Control – Negative, Positive, and Multi-level Controls",,,,Cellular Immunology – Leukocyte Function
,,NM S1,,,Single Platform Requirements,,,,"Cellular Immunology – Non-Malignant Leukocyte
Immunophenotyping"
,,GT S3,,,Test Procedure,,,,Genetic Testing
,,HC S1,,,Test Procedure,,,,Histocompatibility
,,IH S4,,,Standard Operating Procedure,,,,Immunohematology
,,MB S7,,,Laboratory Response Network,,,,Microbiology
,,BT S5,,,Defining Antibiotic Panels,,,,Microbiology – Bacteriology
,,MY S8,,,Antifungal Susceptibility Testing Quality Control,,,,Microbiology – Mycology
,,PS S5,,,Examination of Blood Smears,,,,Microbiology – Parasitology
,,VR S2,,,Cell Culture Records,,,,Microbiology – Virology
,,VR S3,,,Cell Culture Shelf Life and Condition,,,,Microbiology – Virology
,,VR S7,,,Viral Culture Criteria and Timepoints,,,,Microbiology – Virology
,,PIT S6,,,Test Procedure Content,,,,Parentage/Identity Testing
Section or Category,,,Abbreviation,,,Standard title,,,
,,REP S2,,,Test Report Content,,,,General Systems
,,BL S8,,,Reporting Potential Contamination,,,,Blood Lead
,,BL S9,,,Reporting Potential for Fingerstick Contamination,,,,Blood Lead
,,BL S11,,,Reporting,,,,Blood Lead
,,BLS S4,,,Repeat Analysis,,,,Blood Lead ASV Sensor
,,BLS S5,,,Potential for Fingerstick Contamination,,,,Blood Lead ASV Sensor
,,CI S5,,,Viability Reporting,,,,Cellular Immunology
,,LF S13,,,Proliferation Reporting,,,,Cellular Immunology – Leukocyte Function
,,LF S14,,,Reporting Flow Cytometric Results for Functional Analysis,,,,Cellular Immunology – Leukocyte Function
,,NM S13,,,CD34 Stem Cell Enumeration – Reporting Requirements,,,,"Cellular Immunology - Non-Malignant Leukocyte
Immunophenotyping"
,,NM S17,,,"Paroxysmal Nocturnal Hemoglobinuria Diagnosis – Review Criteria and
Reporting",,,,"Cellular Immunology - Non-Malignant Leukocyte
Immunophenotyping"
,,NM S19,,,"Leukocyte Adhesion Deficiency (unstimulated expression) – Report
Requirements",,,,"Cellular Immunology - Non-Malignant Leukocyte
Immunophenotyping"
,,ML S4,,,Report Requirements,,,,"Cellular Immunology – Malignant Leukocyte
Immunophenotyping"
,,CT S2,,,Qualitative Testing,,,,Clinical Toxicology
,,CT S3,,,Reports,,,,Clinical Toxicology
,,CG S12,,,Reporting,,,,Cytogenetics
,,DI S1,,,Syphilis Screening Algorithm Using Nontreponemal Tests,,,,Diagnostic Immunology
,,DI S2,,,Syphilis Screening Algorithm Using Treponemal Tests,,,,Diagnostic Immunology
,,DI S5,,,Reporting Preliminary Positive HIV Test Results,,,,Diagnostic Immunology
,,FI 20,,,Reports and Case Files,,,,Forensic Identity
Section or Category,,,Abbreviation,,,Standard title,,,
,,FT S30,,,Authorized Reporting – Initial Testing Only Laboratories,,,,Forensic Toxicology
,,FT S32,,,Confirmation Testing Report Content,,,,Forensic Toxicology
,,GT S6,,,Report Content,,,,Genetic Testing
,,MB S6,,,Reports,,,,Microbiology
,,MNA S3,,,Reports for Laboratory Developed Sequence-based Assays,,,,Microbiology Nucleic Acid Amplification Assay
,,TB S5,,,Reporting Smear Results,,,,Microbiology – Mycobacteriology
,,PS S7,,,Report Content,,,,Microbiology – Parasitology
,,PS S8,,,Single-Use Antigen Assays,,,,Microbiology – Parasitology
,,PS S9,,,Reporting Negative Results,,,,Microbiology – Parasitology
,,OC S1,,,Soluble Tumor Marker Report Requirements,,,,Oncology – Soluble Tumor Markers
,,OC S2,,,Molecular and Cellular Tumor Markers Report Requirements,,,,Oncology – Molecular and Cellular Tumor Markers
,,PIT S8,,,Report Content,,,,Parentage/Identity Testing
,,CY S15,,,Reporting,,,,Cytopathology
,,HT S2,,,Report Nomenclature,,,,Histopathology
,,TE S9,,,Reporting Potential Contamination,,,,Trace Elements
